<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName nlm2jats3.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Mol Biosci</journal-id><journal-id journal-id-type="iso-abbrev">Front Mol Biosci</journal-id><journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id><journal-title-group><journal-title>Frontiers in Molecular Biosciences</journal-title></journal-title-group><issn pub-type="epub">2296-889X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8193676</article-id><article-id pub-id-type="publisher-id">655584</article-id><article-id pub-id-type="doi">10.3389/fmolb.2021.655584</article-id><article-categories><subj-group subj-group-type="heading"><subject>Molecular Biosciences</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Green Approach: &#x02018;&#x02018;A Forwarding Step for Curing Leishmaniasis&#x02014;A Neglected Tropical Disease&#x02019;&#x02019;</article-title><alt-title alt-title-type="left-running-head">Sharma et al.</alt-title><alt-title alt-title-type="right-running-head">Leishmaniasis: A Neglected Tropical Disease</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Sharma</surname><given-names>Lakshika</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dhiman</surname><given-names>Mamta</given-names></name></contrib><contrib contrib-type="author"><name><surname>Singh</surname><given-names>Abhijeet</given-names></name><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/972904/overview"/></contrib><contrib contrib-type="author"><name><surname>Sharma</surname><given-names>M. M.</given-names></name><xref ref-type="corresp" rid="c001">*</xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/1191216/overview"/></contrib></contrib-group><aff>Department of Biosciences, Manipal University Jaipur, <addr-line>Jaipur</addr-line>, <country>India</country>
</aff><author-notes><fn fn-type="edited-by"><p>
<bold>Edited by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/944900/overview">Diptiman Choudhury</ext-link>, Thapar Institute of Engineering and Technology, India</p></fn><fn fn-type="edited-by"><p>
<bold>Reviewed by:</bold>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/755993/overview">Patrick Valere Tsouh Fokou</ext-link>, The University of Bamenda, Cameroon</p><p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1130569/overview">Satabdi Datta Choudhury</ext-link>, Sri Guru Granth Sahib World University, India</p></fn><corresp id="c001">*Correspondence: M. M. Sharma, <email>madanmohan.sharma@jaipur.manipal.edu</email></corresp><fn fn-type="other"><p>This article was submitted to Molecular Diagnostics and Therapeutics, a section of the journal Frontiers in Molecular Biosciences</p></fn></author-notes><pub-date pub-type="epub"><day>28</day><month>5</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>8</volume><elocation-id>655584</elocation-id><history><date date-type="received"><day>19</day><month>1</month><year>2021</year></date><date date-type="accepted"><day>04</day><month>5</month><year>2021</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2021 Sharma, Dhiman, Singh and Sharma.</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Sharma, Dhiman, Singh and Sharma</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>The present review focuses on a dreaded vector-mediated leishmaniasis, with the existing therapeutic approaches including a variety of drugs along with their limitations, the treatment with natural compounds, and different types of metal/metal oxide nanoparticles (NPs). As evidenced, various metallic NPs, comprising silver, silver oxide, gold, zinc oxide, titanium, lead oxide, <italic>etc.</italic>, played a curative role to treat leishmaniasis, are also presented. Keeping in view the advance success of vaccines against the prevalent dreaded diseases in the past and the present scenario, efforts are also being made to develop vaccines based on these NP formulations.</p></abstract><kwd-group><kwd>leishmaniasis</kwd><kwd>natural sources</kwd><kwd>nanobiotech</kwd><kwd>green route</kwd><kwd>nanoformulations</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Neglected tropical diseases (NTDs) are contagious diseases that cause substantial illness in more than one billion people globally (<xref rid="B47" ref-type="bibr">Maheshwari and Bandyopadhyay, 2020</xref>). Various parasite-mediated diseases comprising giardiasis, Chagas disease, Babesiosis, toxoplasmosis, leishmaniasis, <italic>etc.</italic>, befall in animals and further spread to human population (<xref rid="B63" ref-type="bibr">Oryan, 2015</xref>; <xref rid="B34" ref-type="bibr">Hotez et al., 2020</xref>). Leishmaniasis is one of the NTDs considered as imperative parasitic diseases, commonly caused by an etiologic agent <italic>Leishmania</italic>, a genus of trypanosomes. Leishmaniasis is located in the ninth place of the global burden of disease among individual infectious diseases. More than 22 species of infectious <italic>Leishmania</italic> have been reported (<xref rid="B47" ref-type="bibr">Maheshwari and Bandyopadhyay, 2020</xref>). <italic>Leishmania</italic> are transmitted to mammals through the bite of infected female sandflies belonging to <italic>Lutzomyia</italic> and <italic>Phlebotomus</italic> (<xref rid="B62" ref-type="bibr">Oryan and Akbari, 2016</xref>). It is endemic in 98 nations of the world, where more than 350 million people are at risk and more than 12 million cases of infection have been reported (<xref rid="B82" ref-type="bibr">Verma and Dey, 2004</xref>; <xref rid="B50" ref-type="bibr">Mcgwire and Satoskar, 2014</xref>). Based on the species and intensity of infection to the host, it has been classified into cutaneous leishmaniasis (CL), mucocutaneous leishmaniasis (MCL), and visceral leishmaniasis (VL) forms. Considering these classes, CL caused <italic>by L. aethiopica</italic> is most commonly found in human population and reported to infect 6,00,000 to one million people annually all around the world. It causes severe symptoms like ulcers, serious disabilities, and life-long marks (<xref rid="B80" ref-type="bibr">Surur et al., 2020</xref>). Previously, various chemical drugs including liposomal amphotericin B, amphotericin B, pentamidine, pentavalent antimonials, miltefosine, and paromomycin have been practiced against <italic>Leishmania</italic>. Among these drugs, pentavalent antimonials (sodium stibogluconate and meglumine) are existing chemical drugs, and they are a major therapeutic source to treat <italic>Leishmania</italic> infection. However, current treatment practices are associated with certain side effects like high toxicity, high cost, and most importantly, development of drug resistance. Hence, there is an instantaneous necessity to innovate new, harmless, and efficient prevention therapies to overcome these limitations (<xref rid="B53" ref-type="bibr">Mitropoulos et al., 2010</xref>). Currently, various approaches are involved to control the elevated level of infection, including nanoformulations and targeted drug delivery using nanocarriers as well as with the aid of particular bioactive compound obtained from plants (<xref rid="B38" ref-type="bibr">Javed et al., 2020</xref>; <xref rid="B73" ref-type="bibr">Santana et al., 2020</xref>). Inventions in nanoscience greatly contribute to overcome the problems allied with the treatment of infectious diseases. Owing to the small size of NPs (1&#x02013;100&#x000a0;nm), the ability to penetrate easily into the cells, extensive circulation within the body, and the efficient targeted drug delivery system, they can be reflected as a better medication to treat endemic leishmaniasis (<xref rid="B24" ref-type="bibr">Ebrahimi et al., 2017</xref>). Further, plant-based nanoparticles have been reported as a successful approach for the preclusion of microbial infections as well as in the treatment of leishmaniasis (<xref rid="B5" ref-type="bibr">Alti et al., 2020</xref>). Owing to the green and eco-friendly nature, cost effectiveness, less hazardous nature, and involvement of phytoconstituents for capping and stabilization, plant-based metal oxide nanoparticles (NPs) (silver, zinc, nickel, iron, <italic>etc.</italic>) have been in use to cure leishmanial infection (<xref rid="B36" ref-type="bibr">Ismail et al., 2019</xref>; <xref rid="B5" ref-type="bibr">Alti et al., 2020</xref>). The present review focuses on the use of plant-based natural products, the phytosynthesized NPs, to cure <italic>Leishmania</italic>.</p></sec><sec id="s2"><title>Life Cycle</title><p>The life cycle of <italic>Leishmania</italic> parasite begins with the bite of infected female phlebotomine sandflies and is completed in two different morphological forms, that is, promastigote and amastigote. Flagellated metacyclic promastigote, formed in the infected sandflies firstly enter into the macrophages via phagocytosis and formed phagosome. Resultant phagosome enter into the stages of maturation (membrane transformation) and formed a new structure: the parasitophorous vacuole. In this organelle, promastigotes metamorphose into amastigote, followed by its multiplication until explosion of the cells of the macrophage system (4&#x02013;6&#x000b0;days) spreads infection further. The parasite either initiates infection superficial cells or visceral cell depending on its tropism characteristics. The life cycle of <italic>Leishmania</italic> into the host is completed when another uninfected sandfly sucks blood as a source of meal. The sensitivity of infection is based on the sandfly species, ecology, epidemiology, and pathogenicity (<xref rid="B13" ref-type="bibr">Ba&#x000f1;uls et al., 2007</xref>). Further, detailed description of its infection period and transmission is clearly shown in <xref ref-type="fig" rid="F1">Figure 1</xref>.</p><fig id="F1" position="float"><label>FIGURE 1</label><caption><p>Infection cycle and mechanism of action of NPs in the treatment of <italic>Leishmania</italic>.</p></caption><graphic xlink:href="fmolb-08-655584-g001"/></fig></sec><sec id="s3"><title>Existing Therapeutic Approaches and Limitations</title><p>Leishmaniasis is one of the most important NTDs coupled with various adverse as well as life-threating factors, including substantial morbidity, early death, and long-term infirmity. Treatment comprises control of disease spreading and use of existing parameters, while the currently used therapies including chemical drugs necessitate long-duration therapy and low efficiency with numerous toxic effects. Although no relevant therapies have been developed to prevent the infection which is extensively spread among human population, only few prevention methods are available (<xref rid="B28" ref-type="bibr">Gharirvand Eskandari et al., 2020</xref>). Among them, some kind of clinically approved drugs are found to treat this endemic disease, including meglumine antimoniate (glucatime), sodium stibogluconate (pentostan), amphotericin B, and miltefosine<italic>.</italic> However, the excessive use of these chemotherapeutic sources is associated with antagonistic effects (<xref rid="B29" ref-type="bibr">Ghobakhloo et al., 2016</xref>). This has led to the search of some natural methods to treat leishmaniasis.</p><sec id="s3-1"><title>Chemical-Based Drugs for the Treatment of Leishmaniasis</title><p>Since last several years, various kinds of pharmaceutical drugs including amphotericin B, pentamidine, miltefosine, and paromomycin were involved in the treatment of leishmaniasis. None of the clinically approved drugs could be deliberated as the ultimate source of treatment due to their time-taking process and high toxicity combined with severe adversative effects. In addition, the most often used medicines do not eradicate the parasites entirely from all infected entities (<xref rid="B22" ref-type="bibr">De Menezes et al., 2015</xref>). Further, applications of some of these medicines with their limitations are described below:<list list-type="simple"><list-item><p>&#x02022; Pentavalent antimonials can be administrated by the intravenous, intramuscular, and intralymphatic routes with the optimum dosage of 20&#x000a0;mg/kg/day (28&#x02013;30&#x000a0;days) and exhibited 35&#x02013;95% potentiality. Continuous and excessive use of this drug causes toxicity like nephrotoxicity, hepatotoxicity, severe cardiotoxicity, and pancreatitis (<xref rid="B22" ref-type="bibr">De Menezes et al., 2015</xref>)<italic>.</italic>
</p></list-item><list-item><p>&#x02022; Oral administration of miltefosine not only showed inhibitory effects on the growth of <italic>Leishmania</italic> but also affected adversely and created severe infecting symptoms comprising nephrotoxicity, teratogenicity, vomiting and diarrhea, and hepatotoxicity (<xref rid="B79" ref-type="bibr">Sundar et al., 2011</xref>).</p></list-item><list-item><p>&#x02022; Paromomycin, also being used as a therapeutic agent to treat leishmaniasis, reported to show some toxic effects during its treatment phase, like severe nephrotoxicity, hepatotoxicity, and ototoxicity (<xref rid="B39" ref-type="bibr">Jhingran et al., 2009</xref>).</p></list-item><list-item><p>&#x02022; Pentamidine with the prime dosage of 3&#x000a0;mg/kg/day can potentially involve in the retardation of <italic>Leishmania</italic> growth with some severe antagonistic effects such as hypotension, elevated rate of hyperglycemia, tachycardia, pancreatic damage, and electrocardiographic changes (<xref rid="B22" ref-type="bibr">De Menezes et al., 2015</xref>).</p></list-item></list>
</p><p>The existing chemotherapies have a list of short comings comprising high cost, higher toxicity, and acquired resistance toward parasitic strain, and other side effects during their prevention mechanism insisted scientists and medical practitioners to evolve a new therapeutic system to treat NTDs. During the last decades, green therapies involving plant extracts, bioactive compounds, and secondary metabolites derived from particular plant species and different kinds of NPs synthesized using plant extract become promising as well as safer prevention therapies.</p></sec><sec id="s3-2"><title>Natural Methods</title><p>From ancient times, plant-based traditional methods are being used in the therapeutics against various infectious ailments. Currently, plant extract and particular bioactive compound extracted from plants are either directly used as a therapeutic source or as derived herbal drugs for the treatment of leishmaniasis as well as other microbial infection (<xref rid="B63" ref-type="bibr">Oryan, 2015</xref>).</p><sec id="s3-2-1"><title>Involvement of Plant Extracts and Plant-Derived Secondary Metabolites</title><p>The consumption of herbal drugs derived from plants is being used from centuries as a prevention source for NTDs as well as other diseases including bacterial (and their vectors), helminth (and their vectors), fungal, ectoparasitic, protozoan (and their vectors), and viral infections (and their vectors). The use of medicinal plants becomes more advantageous over other chemotherapies due to their nontoxic, environment-friendly, and cost-effective properties. Further natural compounds obtained from plants are considered as a reliable therapeutic source to treat leishmaniasis (<xref rid="B18" ref-type="bibr">Cheuka et al., 2017</xref>).</p><p>
<italic>Ageratum conyzoides</italic>, <italic>Bidens pilosa</italic>, and <italic>Eugenia uniflora</italic> showed efficient leishmanicidal effects. <italic>Bidens pilosa</italic> (root) has been reported for its antileishmanial properties (against <italic>L. amazonensis</italic>, promastigote) with the least IC<sub>50</sub> value (1.5&#x000a0;&#x003bc;g/ml) as compared to other plant species (<xref rid="T1" ref-type="table">Table 1</xref>). Essential oils from <italic>Eugenia uniflorae</italic> potentially inhibit the growth of both the parasitic forms, that is, promastigote and amastigote, of <italic>L. amazonensis</italic>, and <italic>Ageratum conyzoides</italic> has been reported to treat infection caused by <italic>L. donovani</italic> (amastigote form) (<xref rid="B78" ref-type="bibr">Silveira et al., 2021</xref>). E-caryophyllene, the main component of <italic>Melampodium divaricatum</italic> and <italic>Casearia sylvestris</italic> essential oil, has been reported for its promising antileishmanial response against <italic>L. amazonensis</italic> (IC<sub>50</sub> values of 10.7, 10.7, and 14.0&#x000a0;&#x003bc;g/ml) (<xref rid="B56" ref-type="bibr">Moreira et al., 2019</xref>). Moreover, 1,8-cineole, &#x003b1;-pinene, and p-cymene active constituents of <italic>Protium altsonii</italic> and <italic>P. hebetatum</italic> (Burseraceae) exhibited dose-dependent amastigote inhibition with IC<sub>50</sub> of 48.4, 37, and 46&#x000a0;&#x003bc;g/ml, respectively (<xref rid="B73" ref-type="bibr">Santana et al., 2020</xref>). Butanol fraction of <italic>K. odoratissima</italic> with 154.1&#x000a0;&#x003bc;g/ml IC<sub>50</sub> value showed antileishmanial properties against <italic>L. major</italic> promastigote and amastigote (<xref rid="B52" ref-type="bibr">Mirzaei et al., 2020</xref>).</p><table-wrap id="T1" position="float"><label>TABLE 1</label><caption><p>Role of plant-based natural products in the treatment of leishmaniasis.</p></caption><table frame="hsides" rules="groups"><thead valign="top"><tr><th align="left" rowspan="1" colspan="1">S. no</th><th align="center" rowspan="1" colspan="1">Plant used</th><th align="center" rowspan="1" colspan="1">Plant part used for extract preparation</th><th align="center" rowspan="1" colspan="1">Bioactive compound involved</th><th align="center" rowspan="1" colspan="1">Mode of study and optimum dosages</th><th colspan="2" align="center" rowspan="1">Organism tested</th><th align="center" rowspan="1" colspan="1">Structural formula</th><th align="center" rowspan="1" colspan="1">Mechanism of action</th><th align="center" rowspan="1" colspan="1">References</th></tr></thead><tbody valign="top"><tr><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1">
<italic>Baccharis uncinella</italic> (groundsel)</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">Ursolic acid</td><td align="center" rowspan="1" colspan="1">
<italic>In vivo</italic> 1.0&#x000a0;mg/kg or 2.0&#x000a0;mg/kg (body weight)</td><td colspan="2" align="center" rowspan="1">
<italic>L. infantum</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx1.jpg"/>
</td><td align="center" rowspan="1" colspan="1">Treatment with ursolic acid causes a remarkable reduction in liver as well as splenic parasitism</td><td align="left" rowspan="1" colspan="1">
<xref rid="B37" ref-type="bibr">Jesus et al. (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="center" rowspan="1" colspan="1">
<italic>Allium sativum</italic> (garlic)</td><td align="center" rowspan="1" colspan="1">Bulb</td><td align="center" rowspan="1" colspan="1">Allicin</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> and <italic>in vivo</italic> 50&#x000a0;&#x003bc;M for <italic>in vitro</italic> studies</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx2.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B51" ref-type="bibr">Metwally et al. (2016)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="center" rowspan="1" colspan="1">
<italic>Eremurus persicus</italic> (desert candles)</td><td align="center" rowspan="1" colspan="1">Root extract</td><td align="center" rowspan="1" colspan="1">Aloesaponol III 8-methyl ether</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> 73&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. infantum</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx3.jpg"/>
</td><td align="center" rowspan="1" colspan="1">After treatment with isolated compound, mitochondrial potential and few structural alterations in the promastigote form of tested organism were observed</td><td align="left" rowspan="1" colspan="1">
<xref rid="B69" ref-type="bibr">Rossi et al. (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">4</td><td align="center" rowspan="1" colspan="1">
<italic>Olea europaea</italic> (wild olive, Indian olive, and brown olive)</td><td align="center" rowspan="1" colspan="1">Air-dried, pulverized leaves</td><td align="center" rowspan="1" colspan="1">Oleuropein</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> and <italic>in vivo</italic> 128.4&#x000a0;&#x003bc;M (69.4&#x000a0;&#x003bc;g/ml), for <italic>in vitro</italic> studies</td><td colspan="2" align="center" rowspan="1">
<italic>L. donovani</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx4.jpg"/>
</td><td align="center" rowspan="1" colspan="1">Oleuropein responsible to raise ROS production, upregulation of host antioxidant enzymes, and downregulation of other enzymes of the parasite. Furthermore, <italic>in vivo</italic> model delayed-type hypersensitivity and elevation of IgG2a/IgG1 ratio (leishmania-specific) were observed</td><td align="left" rowspan="1" colspan="1">
<xref rid="B45" ref-type="bibr">Kyriazis et al. (2016)</xref>;<xref rid="B76" ref-type="bibr">Sharma et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">5</td><td align="center" rowspan="1" colspan="1">
<italic>Zingiber zerumbet</italic> (awapuhi and bitter ginger)</td><td align="center" rowspan="1" colspan="1">Fresh rhizome</td><td align="center" rowspan="1" colspan="1">Zerumbone</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> 10&#x000a0;&#x003bc;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. donovani</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx5.jpg"/>
</td><td align="center" rowspan="1" colspan="1">Zerumbone extracted from <italic>Zingiber zerumbet</italic> causes apoptosis in promastigotes by affecting ROS production coupled with reduction of intracellular amastigotes in infected macrophages</td><td align="left" rowspan="1" colspan="1">
<xref rid="B58" ref-type="bibr">Mukherjee et al. (2016)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">6</td><td align="center" rowspan="1" colspan="1">
<italic>Morinda lucida</italic> (brimstone tree)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Molucidin</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> 4.24&#x000a0;&#x003bc;M for <italic>Leishmania hertigi</italic> and anti-010 activity with MIC of 4.167&#x000a0;&#x003bc;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. hertigi</italic> and field strain-010</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx6.jpg"/>
</td><td align="center" rowspan="1" colspan="1">Molucidin: Normal cells have single set of nucleus and kinetoplast, that is, 1N/1K, but molucidin stimulates two different sets of kinetoplast and nucleus in the cells of parasite. After division of both the sets, this compound obstructs the cytokinesis and causes cell cycle arrest which leads to death of parasites</td><td align="left" rowspan="1" colspan="1">
<xref rid="B7" ref-type="bibr">Amoa-Bosompem et al. (2016)</xref>;<xref rid="B76" ref-type="bibr">Sharma et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">7</td><td align="center" rowspan="1" colspan="1">
<italic>Artemisia annua</italic> (sweet annie, annual mugwort, sweet sagewort, or annual wormwood)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Artemisinin</td><td align="center" rowspan="1" colspan="1">
<italic>In vivo</italic> and <italic>in vitro</italic> 100&#x000a0;&#x003bc;g/ml for <italic>in vivo</italic> studies</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx7.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B27" ref-type="bibr">Ghaffarifar et al. (2015)</xref>; <xref rid="B76" ref-type="bibr">Sharma et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">8</td><td align="center" rowspan="1" colspan="1">
<italic>Hypericum Carinatum</italic> (St John&#x02019;s wort)</td><td align="center" rowspan="1" colspan="1">Flowering aerial parts</td><td align="center" rowspan="1" colspan="1">Cariphenone A (1), isouliginosin B (2), and uliginosin B (3)</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> values of 10.5, 17.5, and 11.3&#x000a0;&#x000b5;M for compound 1, 2, and 3, respectively.</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">1<inline-graphic xlink:href="fmolb-08-655584-fx8.jpg"/>2<inline-graphic xlink:href="fmolb-08-655584-fx9.jpg"/>3<inline-graphic xlink:href="fmolb-08-655584-fx10.jpg"/>
</td><td align="center" rowspan="1" colspan="1">Inhibition of parasites mediated by oxidative stress (ROS production) and alteration in mitochondrial potential-like hyperpolarization condition</td><td align="left" rowspan="1" colspan="1">
<xref rid="B20" ref-type="bibr">Dagnino et al. (2018</xref>)</td></tr><tr><td align="left" rowspan="1" colspan="1">9</td><td align="center" rowspan="1" colspan="1">
<italic>Euphorbia peplus</italic> (radium weed)</td><td align="center" rowspan="1" colspan="1">Peplus aerial parts</td><td align="center" rowspan="1" colspan="1">Simiarenol</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> values of 20.24, 34.87, and 32.05&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. donovani</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx11.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B54" ref-type="bibr">Moawad et al. (2016)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">10</td><td align="center" rowspan="1" colspan="1">
<italic>Strychnos pseudoquina</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Strychnobiflavone</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> 5.4 and 18.9&#x000a0;&#x003bc;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Mechanism of action will be allied with alteration in mitochondrial membrane potential in parasitic cells</td><td align="left" rowspan="1" colspan="1">
<xref rid="B146" ref-type="bibr">Lage et al., 2015</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">11</td><td align="center" rowspan="1" colspan="1">
<italic>Melampodium divaricatum</italic> (butter daisy) and <italic>Casearia sylvestris</italic>
</td><td align="center" rowspan="1" colspan="1">Essential oils ( aerial parts of <italic>Melampodium divaricatum</italic> and leaves of <italic>Casearia sylvestris</italic>
</td><td align="center" rowspan="1" colspan="1">E-caryophyllene (22.2%), germacrene D (19.6%), and bicyclogermacrene (12.2%)</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> 24.2, 29.8, and 49.9&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">1<inline-graphic xlink:href="fmolb-08-655584-fx12.jpg"/>2<inline-graphic xlink:href="fmolb-08-655584-fx13.jpg"/>3<inline-graphic xlink:href="fmolb-08-655584-fx14.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B56" ref-type="bibr">Moreira et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">12</td><td align="center" rowspan="1" colspan="1">
<italic>Handroanthus</italic> species</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Lapachol</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> and <italic>in vivo</italic> (IC<sub>50</sub> = 79.84 &#x000b1; 9.10&#x000a0;&#x003bc;M, SI = 42.65) for <italic>L. amazonensis</italic> and (IC<sub>50</sub> = 135.79 &#x000b1; 33.04&#x000a0;&#x003bc;M, SI = 25.08) for <italic>L. infantum</italic> 25&#x000a0;mg/kg for <italic>in vivo</italic> model</td><td colspan="2" align="center" rowspan="1">
<italic>L. infantum</italic> and <italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx15.jpg"/>
</td><td align="center" rowspan="1" colspan="1">In the <italic>in vivo</italic> model, lapachol will be able to reduce the parasitic load in the spleen, liver, and skin lesions</td><td align="left" rowspan="1" colspan="1">
<xref rid="B8" ref-type="bibr">Ara&#x000fa;jo et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">
<italic>Ifloga spicata</italic> (<italic>I. spicata</italic>) (alj al anza, alj al ghazal, and hasaj)</td><td align="center" rowspan="1" colspan="1">Whole plant (leaves, flowers, stem, and roots)</td><td align="center" rowspan="1" colspan="1">3,4-Dihydroxybenzoate (compound 1) and benzoate (compound 2)</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> LD<sub>50</sub> values of 10.40 &#x000b1; 0.09 and 14.11 &#x000b1; 0.11&#x000a0;&#x003bc;g/ml for compound 1 and compound 2, respectively.</td><td colspan="2" align="center" rowspan="1">
<italic>L. tropica</italic>
</td><td align="center" rowspan="1" colspan="1">1<inline-graphic xlink:href="fmolb-08-655584-fx16.jpg"/>2<inline-graphic xlink:href="fmolb-08-655584-fx17.jpg"/>
</td><td align="center" rowspan="1" colspan="1">Both the isolated compounds showed great affinity with gp63 (leishmanolysin) receptor of leishmania parasite. Binding of these compounds with their receptors resulted in the smooth entry of parasites into the cells, and after injection, it binds with DNA and causes apoptosis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B74" ref-type="bibr">Shah et al. (2019)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">14</td><td align="center" rowspan="1" colspan="1">
<italic>Protium altsonii</italic> (PaEO) and <italic>P. hebetatum</italic> (PhEO)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Essential oil</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> PaEO IC<sub>50</sub> were 14.8&#x000a0;&#x003bc;g/ml and 7.8&#x000a0;&#x003bc;g/ml and PhEO IC<sub>50</sub> were 0.46&#x000a0;&#x003bc;g/ml and 30.5&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Mitochondrial membrane potential associated with NO production could be an effective mechanism of leishmaniasis</td><td align="left" rowspan="1" colspan="1">
<xref rid="B73" ref-type="bibr">Santana et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">15</td><td align="center" rowspan="1" colspan="1">
<italic>Artemisia aucheri</italic>
</td><td align="center" rowspan="1" colspan="1">Whole plant extract</td><td align="center" rowspan="1" colspan="1">
<italic>-</italic>
</td><td align="center" rowspan="1" colspan="1">
<italic>In Vitro</italic> and <italic>in vivo</italic> IC<sub>50</sub> 90&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">
<xref rid="B40" ref-type="bibr">KarimiPourSaryazdi et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">16</td><td align="center" rowspan="1" colspan="1">
<italic>Clerodendrum myricoides</italic> (blue-flowered tinder wood) and <italic>Salvadora persica</italic> (arak, jhak, p&#x0012b;lu, <italic>Salvadora indica</italic>, toothbrush tree, mustard tree)</td><td align="center" rowspan="1" colspan="1">Aqueous extract of stem</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> MIC = 625&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B48" ref-type="bibr">Maina et al.(2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">
<italic>Croton blanchetianus</italic> Baill</td><td align="center" rowspan="1" colspan="1">Ethanolic extract</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> values of 208.6 and 8.8&#x000a0;&#x003bc;g/ml for <italic>Leishmania infantum</italic> and IC50 values of 73.6 and 3.1&#x000a0;&#x003bc;g/ml for <italic>Leishmania amazonensis</italic> promastigotes and amastigotes</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic> and <italic>L. infantum</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">Ethanolic extract of <italic>Croton blanchetianus</italic> targets a significant depolarization of mitochondrial membrane potential and leads to mitochondrial dysfunction</td><td align="left" rowspan="1" colspan="1">
<xref rid="B65" ref-type="bibr">Pereira et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">18</td><td align="center" rowspan="1" colspan="1">
<italic>Prunus armeniaca</italic> (Armenian plum)</td><td align="center" rowspan="1" colspan="1">Leaf extract</td><td align="center" rowspan="1" colspan="1">1, 2-benzenedicarboxylic acid and diisooctyl ester</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> anti-promastigote activity with IC<sub>50</sub> 11.48 &#x000b1; 0.82&#x000a0;&#x003bc;g/ml and anti-amastigotes activity with IC50 21.03 &#x000b1; 0.98&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. tropica</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx18.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B75" ref-type="bibr">Shaheen et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">19</td><td align="center" rowspan="1" colspan="1">
<italic>Urtica dioica</italic> (common nettle, stinging nettle)</td><td align="center" rowspan="1" colspan="1">Aqueous extract</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">
<italic>In vivo and in vitro</italic> 3,500 and 6,000&#x000a0;&#x003bc;g/ml for promastigotes and amastigotes, respectively.</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">It proficiently killed the amastigote form of <italic>L. major</italic>; additionally, remarkable reduction of parasite load, skin lesion size, and IL-4, and significant increase of NO and IFN-&#x003b3; were observed</td><td align="left" rowspan="1" colspan="1">
<xref rid="B10" ref-type="bibr">Badirzadeh et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">20</td><td align="center" rowspan="1" colspan="1">
<italic>Piper marginatum</italic> (cake bush, anesi wiwiri, marigold pepper)</td><td align="center" rowspan="1" colspan="1">Leaves (ethanolic extract)</td><td align="center" rowspan="1" colspan="1">3,4-Methylenedioxypropiophenone</td><td align="center" rowspan="1" colspan="1">
<italic>In vivo</italic>
</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx19.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B46" ref-type="bibr">Mac&#x000ea;do et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">21</td><td align="center" rowspan="1" colspan="1">
<italic>Kelussia odoratissima</italic> (kelus celery and wild celery)</td><td align="center" rowspan="1" colspan="1">Dried leaves (butanol fraction)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> half (IC<sub>50</sub>) 264.1 and 154.1&#x000a0;&#x003bc;g/ml for promastigotes and amastigotes, respectively.</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="left" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B52" ref-type="bibr">Mirzaei et al. (2020)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">
<italic>Tabernaemontana coronaria</italic> (milkwood)</td><td align="center" rowspan="1" colspan="1">Dried powder of stem bark</td><td align="center" rowspan="1" colspan="1">Voacamine</td><td align="center" rowspan="1" colspan="1">
<italic>In vivo</italic> IC<sub>50</sub> value was found to be 14.702 &#x000b1; 0.101&#x000a0;mM</td><td colspan="2" align="center" rowspan="1">
<italic>L. donovani</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx20.jpg"/>
</td><td align="center" rowspan="1" colspan="1">Voacamine supresses the relaxation potential of LdTop1B (<italic>L. donovani</italic> toposoisomerase IB) and makes the clevable complex steady</td><td align="left" rowspan="1" colspan="1">
<xref rid="B19" ref-type="bibr">Chowdhury et al. (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">23</td><td align="center" rowspan="1" colspan="1">
<italic>Picramnia gracilis</italic> (bitterbush)</td><td align="center" rowspan="1" colspan="1">Powder of dried leaves</td><td align="center" rowspan="1" colspan="1">5,3&#x02032;-hydroxy-7,4&#x02032;- dimethoxyflavanone</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> and <italic>in vivo</italic> EC<sub>50</sub> 17.0 + 2.8&#x000a0;mg/ml, 53.7&#x000a0;&#x000b5;M for <italic>in vitro</italic> and 2&#x000a0;mg/kg/day for <italic>in vivo</italic> studies</td><td colspan="2" align="center" rowspan="1">
<italic>L. braziliensis</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx21.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B67" ref-type="bibr">Robledo et al. (2015)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">
<italic>Lindera aggregate</italic> (spice bush)</td><td align="center" rowspan="1" colspan="1">Leaves/bark</td><td align="center" rowspan="1" colspan="1">Boldine</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> 600&#x000a0;&#x003bc;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx22.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B70" ref-type="bibr">Salama et al. (2017)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">
<italic>Hypericum andinum</italic>
</td><td align="center" rowspan="1" colspan="1">Dried and powered materials of aerial parts</td><td align="center" rowspan="1" colspan="1">Uliginosin B</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> (IC<sub>50</sub>) of 36.1&#x000a0;g/ml</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx23.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B21" ref-type="bibr">Dagnino et al. (2015)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">
<italic>Amphilophium crucigerum</italic> (monkey&#x02019;s comb)</td><td align="center" rowspan="1" colspan="1">Aerial parts</td><td align="center" rowspan="1" colspan="1">Ipolamiide</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> = 100&#x000a0;&#x000b5;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. amazonensis</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx24.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B81" ref-type="bibr">Vendruscolo et al. (2018)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">
<italic>Valeriana jatamansi</italic> (Indian Valerian or Tagar)</td><td align="center" rowspan="1" colspan="1">Rhizomes</td><td align="center" rowspan="1" colspan="1">Valepotriates</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> = 2.96&#x000a0;&#x000b5;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B30" ref-type="bibr">Glaser et al. (2015)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">
<italic>Nymphoides indica</italic> (banana plant, robust marshwort, and water snowflake)</td><td align="center" rowspan="1" colspan="1">Leaves</td><td align="center" rowspan="1" colspan="1">3-O-methylquercetin-7-O-&#x003b2;-glucoside</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> 32&#x000a0;&#x003bc;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. infantum</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx25.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B6" ref-type="bibr">Amin et al. (2016)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">29</td><td align="center" rowspan="1" colspan="1">
<italic>Vitex grandifolia</italic> (black plum, chocolate and berry tree)</td><td align="center" rowspan="1" colspan="1">Air-dried leaves</td><td align="center" rowspan="1" colspan="1">Bartioside</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> IC<sub>50</sub> 27.51&#x000a0;&#x000b5;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. donovani</italic>
</td><td align="center" rowspan="1" colspan="1">
<inline-graphic xlink:href="fmolb-08-655584-fx26.jpg"/>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B16" ref-type="bibr">Bello et al. (2018)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">30</td><td align="center" rowspan="1" colspan="1">
<italic>Scrophularia syriaca</italic> (figworts)</td><td align="center" rowspan="1" colspan="1">Aerial parts</td><td align="center" rowspan="1" colspan="1">6-O-a-lrhamnopyranosylcatalpol</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> EC<sub>50</sub> 100&#x000a0;&#x000b5;M</td><td colspan="2" align="center" rowspan="1">
<italic>L. major</italic>
</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">-</td><td align="left" rowspan="1" colspan="1">
<xref rid="B4" ref-type="bibr">Alkhaldi et al. (2020)</xref>
</td></tr><tr><td colspan="10" align="left" rowspan="1">
<bold>Section 2: Natural drugs for treating leishmaniasis</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;<bold>S. no</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Compound (s)</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Company/originator</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Country</bold>
</td><td colspan="2" align="center" rowspan="1">
<bold>Year</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Mode of studies</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Probable mechanism involved</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Patent and IPC</bold>
</td><td align="center" rowspan="1" colspan="1">
<bold>Ref.</bold>
</td></tr><tr><td align="left" rowspan="1" colspan="1">31</td><td align="center" rowspan="1" colspan="1">Ethyl 3-(2- chloroacetamido) benzoate, dihydroquercetin, and bisabolol</td><td align="center" rowspan="1" colspan="1">Auclair et al., AC Bioscience SA</td><td align="center" rowspan="1" colspan="1">Switzerland</td><td colspan="2" align="center" rowspan="1">2019</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> and <italic>in vivo</italic> studies</td><td align="center" rowspan="1" colspan="1">Inhibition of some important parasitic enzymes with tryparedoxin peroxidase and tubulin</td><td align="center" rowspan="1" colspan="1">WO2019043212 and A61K A61P</td><td align="center" rowspan="1" colspan="1">
<xref rid="B31" ref-type="bibr">Hajaji et al. (2018)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">32</td><td align="center" rowspan="1" colspan="1">Diterpenoid membranolides</td><td align="center" rowspan="1" colspan="1">Baker et al., the University of South Florida</td><td align="center" rowspan="1" colspan="1">United States of America</td><td colspan="2" align="center" rowspan="1">2016</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic>
</td><td align="center" rowspan="1" colspan="1">Impedes lipid synthesis</td><td align="center" rowspan="1" colspan="1">US2016003O388 and A61K</td><td align="center" rowspan="1" colspan="1">
<xref rid="B12" ref-type="bibr">Baker et al. (2016)</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">33</td><td align="center" rowspan="1" colspan="1">Withaferin-A and miltefosine</td><td align="center" rowspan="1" colspan="1">Maurya et al., the University of Hyderabad</td><td align="center" rowspan="1" colspan="1">India</td><td colspan="2" align="center" rowspan="1">2017</td><td align="center" rowspan="1" colspan="1">
<italic>In vitro</italic> and <italic>in vivo</italic> studies</td><td align="center" rowspan="1" colspan="1">Inhibits pteridine reductase-1 enzyme, and phosphatidylcholine synthesis, and cytochrome c oxidase</td><td align="center" rowspan="1" colspan="1">WO2017046778and A61K A61P</td><td align="center" rowspan="1" colspan="1">
<xref rid="B49" ref-type="bibr">Maurya and Chandrasekaran (2017)</xref>
</td></tr></tbody></table></table-wrap></sec><sec id="s3-2-2"><title>Role of Plant-Based Nanoparticles in the Treatment of Leishmaniasis</title><p>Methods in controlling infectious diseases have modernized translational sciences to develop a better controlling method for infectious diseases. The field of nanomedicine has shown enormous potential in developing highly sensitive diagnostic tools with excellent drug delivery properties. Recently, nanoparticle-conjugated drugs have increasingly been studied as an alternative, cost-effective therapy with increased effectiveness. However, toxicity is a major barrier that needs to be encountered. Several reports have shown the effective antimicrobial activities of various metal/metal oxide nanoparticles as well as against the <italic>Leishmania</italic> causing organism through their wide surface area and unique properties.</p><p>Nanoparticles synthesized using crude as well as various solvent-fractionated extracts of medically important plants are considered as efficient agents for the delivery of specific phytoconstituents into the cells. Keeping in view the effective antimicrobial activities of silver metal, silver/silver oxide NPs have been synthesized using a variety of medicinally important plant species, including <italic>Mentha arvensis</italic> L., <italic>Ficus benghalensis</italic>, <italic>Cuminum cyminum</italic>, <italic>Moringa oleifera</italic>, <italic>Silybum marianum</italic>, and <italic>Sechium edule</italic>, at a dosage of 10, 300, 0.5, 246, and 51.88&#x000a0;&#x003bc;g/ml tested against <italic>L. tropica</italic>, <italic>L. donovani</italic>, <italic>L. tropica</italic>, <italic>L. major</italic>, <italic>L. tropica</italic>, and <italic>Leishmania donovani</italic>, respectively (<xref rid="B14" ref-type="bibr">Baranwal et al., 2018</xref>; <xref rid="B25" ref-type="bibr">El-Khadragy et al., 2018</xref>; <xref rid="B33" ref-type="bibr">Hameed et al., 2019</xref>; <xref rid="B36" ref-type="bibr">Ismail et al., 2019</xref>; <xref rid="B11" ref-type="bibr">Bagirova et al., 2020</xref>; <xref rid="B38" ref-type="bibr">Javed et al., 2020</xref>). Gold and silver bimetallic NPs synthesized by using medically important plants have also been reported to be used for the prevention of this disease (<xref rid="B5" ref-type="bibr">Alti et al., 2020</xref>). However, <italic>Cannabis sativa</italic>&#x02013;based Au-NPs accomplished virtuous antileishmanial activity against amastigote forms (IC<sub>50</sub>: 171&#x000b7;00 &#x000b1; 2&#x000b7;28&#x000a0;&#x003bc;g/ml) (<xref rid="B32" ref-type="bibr">Hameed et al., 2020</xref>). 7, 8-dihydroxyflavone, a type of flavonoid found abundantly in plants used to produce gold nanoparticles, has also been reported to preclude leishmaniasis (<xref rid="B66" ref-type="bibr">Prasanna et al., 2020</xref>).</p><p>Zno-NPs were also reported to show dose-dependent cytotoxicity against <italic>L. tropica</italic> (IC<sub>50</sub>: 8.30&#x000a0;&#x003bc;g/ml) (<xref rid="B35" ref-type="bibr">Iqbal et al., 2019</xref>). Rod-shaped zinc oxide NPs produced by using <italic>Lilium ledebourii</italic> tuber extract potentially inhibited the growth of <italic>L. major</italic> with the IC<sub>50</sub> value of 0.001&#x000a0;mg&#x000a0;ml<sup>&#x02212;1</sup> (<xref rid="B43" ref-type="bibr">Khatami et al., 2020</xref>). <xref rid="B71" ref-type="bibr">Saleh (2019)</xref> also concluded that green TiO<sub>2</sub> nanoparticles have shown effective roles to counter noxiousness of <italic>Leishmania tropica</italic> in male rats. Hematite (Fe<sub>2</sub>O<sub>3</sub>) NPs fabricated with the <italic>Rhus punjabensis</italic> extract played an efficient role in the treatment of leishmaniasis (<xref rid="B59" ref-type="bibr">Naz et al., 2019</xref>). <xref rid="B42" ref-type="bibr">Khalil et al. (2020)</xref> prepared lead oxide NPs (PbO-NPs) by green route using aqueous leaf extracts of <italic>Sageretia thea</italic>. The experimental data showed that PbO-NPs were significantly active in arresting the growth of promastigote and amastigote forms of <italic>Leishmania tropica</italic>, with 14.7&#x000a0;&#x003bc;g/ml and 11.95&#x000a0;&#x003bc;g/ml IC<sub>50</sub> values, respectively.</p><p>Plant-mediated (<italic>Trigonella foenum-graecum</italic>) iron oxide nanoparticles have been reported to exhibit significant inhibitory effects on <italic>L. tropica</italic> (<xref rid="B3" ref-type="bibr">Ain et al., 2019</xref>). Further, <xref rid="B1" ref-type="bibr">Abbasi et al. (2019)</xref> also stated the antileishmanial efficacy of Nio-NPs fabricated by using <italic>Geranium wallichianum</italic> against <italic>L. tropica</italic>.</p><p>Besides, the nanostructured drug delivery system was also reported in ameliorate NTDs including leishmaniasis. Furthermore, crude plant extracts and precise phytoconstituents obtained from plant which is involved in the prevention mechanism were also loaded in the nanostructured drug delivery system and used as a therapeutic source to cure leishmaniasis, and the mechanism is depicted below:<list list-type="simple"><list-item><p>&#x02022; Liposome NPs consisting of phospholipids are assisted as a transport system for the delivery of hydrophilic as well as lipophilic pharmaceutical drugs (<xref rid="B55" ref-type="bibr">Momeni et al., 2013</xref>). They provide improved pharmacokinetic assets along with target diligence which offers a foremost advantage (<xref rid="B41" ref-type="bibr">Kaye and Scott, 2011</xref>). Liposome can spear the macrophages through phagocytosis and offers direct delivery of the drugs at their targeted sites. Different drug formulations including AmB colloidal formulations, liposomal AmB, and AmB lipid network can overwhelm the toxic effects of conventional drugs (<xref rid="B57" ref-type="bibr">Moreno et al., 2015</xref>). Liposome-encapsulated <italic>Curcuma longa</italic> and <italic>Combretum leprosum</italic> extracts were also reported for their antileishmanial properties (<xref rid="B2" ref-type="bibr">Aditya et al., 2012</xref>; <xref rid="B15" ref-type="bibr">Barros et al., 2013</xref>).</p></list-item><list-item><p>&#x02022; Beta-lapachone extracted from Lapacho tree with the use of lecithin-chitosan NP encapsulation method has been reported in the treatment of leishmaniasis (<xref rid="B57" ref-type="bibr">Moreno et al., 2015</xref>).</p></list-item><list-item><p>&#x02022; 8-hydroxyquinoline with the polymeric micelle encapsulation method has been used to treat <italic>Leishmania</italic> (<xref rid="B23" ref-type="bibr">Duarte et al., 2016</xref>). Berberin, an isoquinoline alkaloid extracted from medicinal plants, has been reported to possess various biologic properties, including antileishmanial properties. A previous study addressed the preparation of BER-loaded liposomes with the aim to prevent its rapid liver metabolism and improve the drug selective delivery to the infected organs in visceral leishmaniasis (VL) (<xref rid="B17" ref-type="bibr">Calvo et al., 2020</xref>).</p></list-item></list>
</p><p>As per the literature survey, plant-based nanoparticles contribute efficient roles in the treatment of leishmaniasis as compared to other existing practices. Phytosynthesized NPs revealed an identical effect on the inhibition of parasitic growth at a comparatively lesser concentration than the prescribed dose of Amp B to cure this disease. Additionally, bimetallic nanoparticles including Au&#x02212;Ag, Zn&#x02212;Ag, and Ti&#x02212;Ag were synthesized using the green approach and proficiently used as a therapeutic source to treat leishmaniasis (<xref rid="B5" ref-type="bibr">Alti et al., 2020</xref>). NPs are preferred over other therapeutic sources to treat this dreaded disease because of their nontoxic, harmless, and efficient delivery system for vaccine<italic>.</italic> Currently, with the advancement of nanosciences, there is a new method of synthesizing vaccines using NPs as carriers of antigen preparation. Solid lipid nanoparticles can assist as an effective tool to produce leishmanial vaccine (<xref rid="B72" ref-type="bibr">Saljoughian et al., 2013</xref>). However, any kind of NP-based vaccine is not accessible, and it needs more consideration.</p></sec></sec></sec><sec id="s4"><title>Restorative Mechanism of Nanoformulations Against Leishmaniasis</title><p>
<italic>Leishmania</italic> sp. are protozoal parasites which result in cutaneous and visceral leishmaniasis. Different clinical studies exhibit the development of self-curable to detrimental conditions, depending upon the immune responses triggered by the affected host (<xref rid="B60" ref-type="bibr">Noormehr et al., 2018</xref>). Chemotherapy with pentavalent antimonials (like sodium stibogluconate or meglumine antimoniate) and other antileishmanial drugs (amphotericin B, fluconazole, pentamidine, and miltefosine) are optimal for leishmanial therapy. However, due to adverse effects, high cost, difficult infusion routes, low cure, and increasing resistance are of significant concern in developing more efficient ways in leishmaniasis therapy. Moreover, the efficacy of the drug used in the treatment also varies for different leishmanial sp. (<xref rid="B60" ref-type="bibr">Noormehr et al., 2018</xref>; <xref rid="B5" ref-type="bibr">Alti et al., 2020</xref>; <xref rid="B17" ref-type="bibr">Calvo et al., 2020</xref>). In self-treatment, the innate immune cells (phagocytes) detect and engulf the causal agents, which induces <italic>Leishmania</italic> assassination by producing reactive oxygen species, nitric oxide, and tumor necrosis factors (<xref rid="B61" ref-type="bibr">Olekhnovitch et al., 2014</xref>). After innate immune responses, respective activation and production of CD8<sup>+</sup>, NK, and IFN cells by TH1 immunity results in killing of <italic>Leishmania</italic> parasites (<xref rid="B60" ref-type="bibr">Noormehr et al., 2018</xref>). In susceptible conditions, the defense system fails to overcome infections, and follows incorrect TH2 immune responses along with antibody response, which is the key factor to generate new ways of parasite elimination. Metal nanoparticles inhibit proliferation and viability of infected cells, which is contingent with the NP strength and time of exposure (<xref rid="B68" ref-type="bibr">Rosas-Hern&#x000e1;ndez et al., 2009</xref>; <xref rid="B26" ref-type="bibr">Fanti et al., 2018</xref>).</p><p>Several <italic>in vitro</italic> as well as <italic>in vivo</italic> findings suggest leishmanicidal effects of bio&#x02013;Ag-NPs by direct (exclusive of inflammatory mediators) or indirect (immunomodulatory) mechanisms (<xref rid="B26" ref-type="bibr">Fanti et al., 2018</xref>; <xref rid="B17" ref-type="bibr">Calvo et al., 2020</xref>). In the direct method, metal-NPs kill the parasitic cells by causing vacuolation inside parasites and damage to the cellular membrane without generating immunomodulatory intermediaries, that is, reactive oxygen species (ROS), nitric oxide (NO), and apoptotic and necrotic factors (<xref rid="B26" ref-type="bibr">Fanti et al., 2018</xref>). In situations when <italic>Leishmania</italic> parasites override the oxidative burst inside phagocytic cells and reside in phagolysosomes, nanoformulations assist site-specific delivery and accumulation of drugs, which is responsible for parasite killing (<xref rid="B77" ref-type="bibr">Shoaib Sarwar et al., 2020</xref>). According to <xref rid="B26" ref-type="bibr">Fanti et al. (2018)</xref>, Ag-NPs after diffusion through the cellular membranes get oxidized due to acidic conditions within the phagolysosomes, and eventually, the release of free Ag + ions causes parasite assassination.</p><p>On the other hand, the indirect method involves immunomodulatory response generation at infection sites. Other ways to provide leishmanicidal effects are through activating immune response mediators in which the cell viability and proliferation get declined as an effect of metallic nanoparticles. NPs basically induce different morphological abrasions such as distorted membranal integrity, cytotoxicity, mitochondrial destruction, cell cycle arrest (G1), increased/decreased ROS and NO generation, affected enzymatic activities, and release of apoptotic or necrotic factors (<xref rid="B64" ref-type="bibr">Park et al., 2010</xref>; <xref rid="B44" ref-type="bibr">Kruszewski et al., 2011</xref>; <xref rid="B83" ref-type="bibr">Zahir et al., 2015</xref>). As a result of mitochondrial disintegration, ATP generation gets influenced, which causes cytotoxic effects, and ultimately affects the infection growth (<xref rid="B9" ref-type="bibr">AshaRani et al., 2009</xref>). Moreover, NP exposure exhibits decreased parasitic load and reduction in an essential parasitic enzyme trypanothione reductase system (<xref rid="B26" ref-type="bibr">Fanti et al., 2018</xref>).</p></sec><sec id="s5"><title>Conclusion and Future Prospective</title><p>Chemotherapy due to lack of effective therapies till date has become the only choice in treating leishmaniasis, as these therapies exhibit higher toxicity levels, treatment cost, and resistance development against leishmanial parasites, and encourage other side effects. In addition, it is evident that the efficiency of drugs varies from species to species due to leishmanial antigen variants and different immunological responses against the drug. To overcome these challenges, biogenic nanomaterials being nontoxic, bio-compatible, cost effective, and having high targeted drug-loading potentials have been indicated as beneficial alternatives to formulate nanovaccines. Targeted drug delivery barriers can be conquered by using nanoformulations for enhanced parasiticidal proficiencies. Also, various studies have demonstrated leishmanicidal activities of plant-derived natural compounds (such as berberine, 7, 8-dihydroxyflavone, E-caryophyllene, essential oil constituents, &#x003b1;-terpineol, glycosides, tannins, and anthraquinone flavonoids), which can further integrate beneficial outcomes. Besides, most of the studies conducted on leishmanicidal activities revealed only the basic outcomes like assessment of the effect of test drugs (crude extract, isolated bioactive compounds, essential oil, and purified fraction) on the parasite growth. Few of them identify the proper formulation as well as the effect on the promastigote stage, found in the sandflies (vector). As widely conferred in the literature, plants possess a variety of bioactive compounds, and most of them have been reported for their pharmaceutical properties. Thus, the standardization may conclude the identification of particular compound responsible for leishmanicidal activities. Biosynthesized nanoparticles majorly eliminate the infection either by triggering the immunomodulatory response of the host or sometimes directly by resulting in vacuolization of parasitic cells, leading to parasite killing. Nanovaccines are a relatively new concept in treating <italic>Leishmania</italic> although no vaccine is yet available, but studies are ongoing to find efficient nanovaccines. Although nanotechnology has provided a hope toward improved and successful eradication of neglected tropical diseases, the accurate molecular mechanism responsible still needs thorough transparency to bring utmost benefits.</p></sec></body><back><ack><p>The work supported by Manipal University Jaipur is gratefully acknowledged. Authors are obliged to Manipal University Jaipur for necessary support and facilities.</p></ack><sec id="s6"><title>Author Contributions</title><p>LS: writing original draft and editing; MD: writing, review, and editing; AS: conceptualization and validation; MS: supervision, conceptualization, and validation.</p></sec><sec sec-type="COI-statement" id="s7"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec id="s10"><title>Supplementary Material</title><p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.655584/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2021.655584/full#supplementary-material</ext-link>.</p><supplementary-material content-type="local-data" id="SM1"><media xlink:href="Table1.DOCX"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec><ref-list><title>References</title><ref id="B1"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Abbasi</surname><given-names>B. A.</given-names></name><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Mahmood</surname><given-names>T.</given-names></name><name><surname>Ahmad</surname><given-names>R.</given-names></name><name><surname>Kanwal</surname><given-names>S.</given-names></name><name><surname>Afridi</surname><given-names>S.</given-names></name></person-group> (<year>2019</year>). <article-title>Plant-mediated Synthesis of Nickel Oxide Nanoparticles (NiO) via Geranium Wallichianum: Characterization and Different Biological Applications</article-title>. <source>Mater. Res. Express</source>
<volume>6</volume>, <fpage>0850a7</fpage>. <pub-id pub-id-type="doi">10.1088/2053-1591/ab23e1</pub-id>
</mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Aditya</surname><given-names>N. P.</given-names></name><name><surname>Chimote</surname><given-names>G.</given-names></name><name><surname>Gunalan</surname><given-names>K.</given-names></name><name><surname>Banerjee</surname><given-names>R.</given-names></name><name><surname>Patankar</surname><given-names>S.</given-names></name><name><surname>Madhusudhan</surname><given-names>B.</given-names></name></person-group> (<year>2012</year>). <article-title>Curcuminoids-loaded Liposomes in Combination with Arteether Protects against Plasmodium Berghei Infection in Mice</article-title>. <source>Exp. Parasitol.</source>
<volume>131</volume>, <fpage>292</fpage>&#x02013;<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2012.04.010</pub-id>
<pub-id pub-id-type="pmid">22561991</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ain</surname><given-names>Q. U.</given-names></name><name><surname>Islam</surname><given-names>A.</given-names></name><name><surname>Nadhman</surname><given-names>A.</given-names></name><name><surname>Yasinzai</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Comparative Analysis of Chemically and Biologically Synthesized Iron Oxide Nanoparticles against Leishmania Tropica</article-title>. <source>bioRxiv</source>. <pub-id pub-id-type="doi">10.1101/829408</pub-id>
</mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alkhaldi</surname><given-names>A. A. M.</given-names></name><name><surname>Musa</surname><given-names>A.</given-names></name><name><surname>Mostafa</surname><given-names>E. M.</given-names></name><name><surname>Amin</surname><given-names>E.</given-names></name><name><surname>De Koning</surname><given-names>H. P.</given-names></name></person-group> (<year>2020</year>). <article-title>Docking Studies and Antiprotozoal Activity of Secondary Metabolites Isolated from Scrophularia Syriaca Benth. Growing in Saudi Arabia</article-title>. <source>Rec.Nat.Prod.</source>
<volume>14</volume>, <fpage>23</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.25135/rnp.19.03.1224</pub-id>
</mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Alti</surname><given-names>D.</given-names></name><name><surname>Veeramohan Rao</surname><given-names>M.</given-names></name><name><surname>Rao</surname><given-names>D. N.</given-names></name><name><surname>Maurya</surname><given-names>R.</given-names></name><name><surname>Kalangi</surname><given-names>S. K.</given-names></name></person-group> (<year>2020</year>). <article-title>Gold-Silver Bimetallic Nanoparticles Reduced with Herbal Leaf Extracts Induce ROS-Mediated Death in Both Promastigote and Amastigote Stages of Leishmania Donovani</article-title>. <source>ACS Omega</source>
<volume>5</volume>, <fpage>16238</fpage>&#x02013;<lpage>16245</lpage>. <pub-id pub-id-type="doi">10.1021/acsomega.0c02032</pub-id>
<pub-id pub-id-type="pmid">32656446</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amin</surname><given-names>A.</given-names></name><name><surname>Tuenter</surname><given-names>E.</given-names></name><name><surname>Exarchou</surname><given-names>V.</given-names></name><name><surname>Upadhyay</surname><given-names>A.</given-names></name><name><surname>Cos</surname><given-names>P.</given-names></name><name><surname>Maes</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Phytochemical and Pharmacological Investigations onNymphoides indicaLeaf Extracts</article-title>. <source>Phytother. Res.</source>
<volume>30</volume>, <fpage>1624</fpage>&#x02013;<lpage>1633</lpage>. <pub-id pub-id-type="doi">10.1002/ptr.5663</pub-id>
<pub-id pub-id-type="pmid">27282639</pub-id></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Amoa-Bosompem</surname><given-names>M.</given-names></name><name><surname>Ohashi</surname><given-names>M.</given-names></name><name><surname>Mosore</surname><given-names>M.-T.</given-names></name><name><surname>Agyapong</surname><given-names>J.</given-names></name><name><surname>Tung</surname><given-names>N. H.</given-names></name><name><surname>Kwofie</surname><given-names>K. D.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>
<italic>In Vitro</italic> anti-leishmania Activity of Tetracyclic Iridoids from Morinda Lucida, Benth</article-title>. <source>Trop. Med. Health</source>
<volume>44</volume>. <fpage>25</fpage>. <pub-id pub-id-type="doi">10.1186/s41182-016-0026-5</pub-id>
<pub-id pub-id-type="pmid">27536194</pub-id></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ara&#x000fa;jo</surname><given-names>I. A. C.</given-names></name><name><surname>de Paula</surname><given-names>R. C.</given-names></name><name><surname>Alves</surname><given-names>C. L.</given-names></name><name><surname>Faria</surname><given-names>K. F.</given-names></name><name><surname>Oliveira</surname><given-names>M. M. d.</given-names></name><name><surname>Mendes</surname><given-names>G. G.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Efficacy of Lapachol on Treatment of Cutaneous and Visceral Leishmaniasis</article-title>. <source>Exp. Parasitol.</source>
<volume>199</volume>, <fpage>67</fpage>&#x02013;<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2019.02.013</pub-id>
<pub-id pub-id-type="pmid">30797783</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>AshaRani</surname><given-names>P. V.</given-names></name><name><surname>Low Kah Mun</surname><given-names>G.</given-names></name><name><surname>Hande</surname><given-names>M. P.</given-names></name><name><surname>Valiyaveettil</surname><given-names>S.</given-names></name></person-group> (<year>2009</year>). <article-title>Cytotoxicity and Genotoxicity of Silver Nanoparticles in Human Cells</article-title>. <source>ACS Nano</source>
<volume>3</volume>, <fpage>279</fpage>&#x02013;<lpage>290</lpage>. <pub-id pub-id-type="doi">10.1021/nn800596w</pub-id>
<pub-id pub-id-type="pmid">19236062</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Badirzadeh</surname><given-names>A.</given-names></name><name><surname>Heidari-Kharaji</surname><given-names>M.</given-names></name><name><surname>Fallah-Omrani</surname><given-names>V.</given-names></name><name><surname>Dabiri</surname><given-names>H.</given-names></name><name><surname>Araghi</surname><given-names>A.</given-names></name><name><surname>Salimi Chirani</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Antileishmanial Activity of Urtica Dioica Extract against Zoonotic Cutaneous Leishmaniasis</article-title>. <source>Plos Negl. Trop. Dis.</source>
<volume>14</volume>, <fpage>e0007843</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pntd.0007843</pub-id>
<pub-id pub-id-type="pmid">31929528</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bagirova</surname><given-names>M.</given-names></name><name><surname>Dinparvar</surname><given-names>S.</given-names></name><name><surname>Allahverdiyev</surname><given-names>A. M.</given-names></name><name><surname>Unal</surname><given-names>K.</given-names></name><name><surname>Abamor</surname><given-names>E. S.</given-names></name><name><surname>Novruzova</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Investigation of Antileshmanial Activities of Cuminum Cyminum Based green Silver Nanoparticles on L. Tropica Promastigotes and Amastigotes <italic>In Vitro</italic>
</article-title>. <source>Acta Tropica</source>
<volume>208</volume>, <fpage>105498</fpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2020.105498</pub-id>
<pub-id pub-id-type="pmid">32428676</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baker</surname><given-names>B. J.</given-names></name><name><surname>Witowski</surname><given-names>C. G.</given-names></name><name><surname>Maschek</surname><given-names>J. A.</given-names></name><name><surname>Vesely</surname><given-names>B.</given-names></name><name><surname>Kyle</surname><given-names>D. E.</given-names></name></person-group> (<year>2016</year>). <article-title>Diterpenoide Membranolide Compounds Having Anti-leishmania Acitivity and Uses Thereof</article-title>. <comment>US 20160030388</comment>
</mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ba&#x000f1;uls</surname><given-names>A. L.</given-names></name><name><surname>Hide</surname><given-names>M.</given-names></name><name><surname>Prugnolle</surname><given-names>F.</given-names></name></person-group> (<year>2007</year>). <article-title>Leishmania and the Leishmaniases: A Parasite Genetic Update and Advances in Taxonomy, Epidemiology and Pathogenicity in Humans</article-title>. <source>Adv. Parasitol.</source>
<volume>64</volume>, <fpage>1</fpage>&#x02013;<lpage>458</lpage>. <pub-id pub-id-type="doi">10.1016/S0065-308X(06)64001-3</pub-id>
<pub-id pub-id-type="pmid">17499100</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Baranwal</surname><given-names>A.</given-names></name><name><surname>Chiranjivi</surname><given-names>A. K.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Dubey</surname><given-names>V. K.</given-names></name><name><surname>Chandra</surname><given-names>P.</given-names></name></person-group> (<year>2018</year>). <article-title>Design of Commercially Comparable Nanotherapeutic Agent against Human Disease-Causing Parasite, Leishmania</article-title>. <source>Sci. Rep.</source>
<volume>8</volume>. <fpage>8814</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-018-27170-1</pub-id>
<pub-id pub-id-type="pmid">29891923</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Barros</surname><given-names>N. B.</given-names></name><name><surname>Migliaccio</surname><given-names>V.</given-names></name><name><surname>Facundo</surname><given-names>V. A.</given-names></name><name><surname>Ciancaglini</surname><given-names>P.</given-names></name><name><surname>St&#x000e1;beli</surname><given-names>R. G.</given-names></name><name><surname>Nicolete</surname><given-names>R.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Liposomal-lupane System as Alternative Chemotherapy against Cutaneous Leishmaniasis: Macrophage as Target Cell</article-title>. <source>Exp. Parasitol.</source>
<volume>135</volume>, <fpage>337</fpage>&#x02013;<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2013.07.022</pub-id>
<pub-id pub-id-type="pmid">23933281</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bello</surname><given-names>O.</given-names></name><name><surname>Ogbesejana</surname><given-names>A.</given-names></name><name><surname>Osibemhe</surname><given-names>M.</given-names></name></person-group> (<year>2018</year>). <article-title>Iridoid Glucosides from <italic>Vitex Grandifolia</italic> Displayed Anti-inflammatory and Antileishmania Effects and Structure Activity Relationship</article-title>. <source>J. Appl. Sci. Environ. Manag.</source>
<volume>22</volume>, <fpage>373</fpage>. <pub-id pub-id-type="doi">10.4314/jasem.v22i3.14</pub-id>
</mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Calvo</surname><given-names>A.</given-names></name><name><surname>Moreno</surname><given-names>E.</given-names></name><name><surname>Larrea</surname><given-names>E.</given-names></name><name><surname>Sanmart&#x000ed;n</surname><given-names>C.</given-names></name><name><surname>Irache</surname><given-names>J. M.</given-names></name><name><surname>Espuelas</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>Berberine-loaded Liposomes for the Treatment of Leishmania Infantum-Infected Balb/c Mice</article-title>. <source>Pharmaceutics</source>
<volume>12</volume>, <fpage>858</fpage>. <pub-id pub-id-type="doi">10.3390/pharmaceutics12090858</pub-id>
</mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Cheuka</surname><given-names>P.</given-names></name><name><surname>Mayoka</surname><given-names>G.</given-names></name><name><surname>Mutai</surname><given-names>P.</given-names></name><name><surname>Chibale</surname><given-names>K.</given-names></name></person-group> (<year>2017</year>). <article-title>The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases</article-title>. <source>Molecules</source>
<volume>22</volume>, <fpage>58</fpage>. <pub-id pub-id-type="doi">10.3390/molecules22010058</pub-id>
</mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Chowdhury</surname><given-names>S. R.</given-names></name><name><surname>Kumar</surname><given-names>A.</given-names></name><name><surname>Godinho</surname><given-names>J. L. P.</given-names></name><name><surname>De Macedo Silva</surname><given-names>S. T.</given-names></name><name><surname>Zuma</surname><given-names>A. A.</given-names></name><name><surname>Saha</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Voacamine Alters Leishmania Ultrastructure and Kills Parasite by Poisoning Unusual Bi-subunit Topoisomerase IB</article-title>. <source>Biochem. Pharmacol.</source>
<volume>138</volume>, <fpage>19</fpage>&#x02013;<lpage>30</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2017.05.002</pub-id>
<pub-id pub-id-type="pmid">28483460</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dagnino</surname><given-names>A. P. A.</given-names></name><name><surname>Mesquita</surname><given-names>C. S.</given-names></name><name><surname>Dorneles</surname><given-names>G. P.</given-names></name><name><surname>Teixeira</surname><given-names>V. D. O. N.</given-names></name><name><surname>De Barros</surname><given-names>F. M. C.</given-names></name><name><surname>Vidal Ccana-Ccapatinta</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Phloroglucinol Derivatives from hypericum Species Trigger Mitochondrial Dysfunction in Leishmania Amazonensis</article-title>. <source>Parasitology</source>
<volume>145</volume>, <fpage>1199</fpage>&#x02013;<lpage>1209</lpage>. <pub-id pub-id-type="doi">10.1017/S0031182018000203</pub-id>
<pub-id pub-id-type="pmid">29482667</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Dagnino</surname><given-names>A. P.</given-names></name><name><surname>Barros</surname><given-names>F. M. C. d.</given-names></name><name><surname>Ccana-Ccapatinta</surname><given-names>G. V.</given-names></name><name><surname>Prophiro</surname><given-names>J. S.</given-names></name><name><surname>Poser</surname><given-names>G. L. v.</given-names></name><name><surname>Rom&#x000e3;o</surname><given-names>P. R. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Leishmanicidal Activity of Lipophilic Extracts of Some Hypericum Species</article-title>. <source>Phytomedicine</source>
<volume>22</volume>, <fpage>71</fpage>&#x02013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1016/j.phymed.2014.10.004</pub-id>
<pub-id pub-id-type="pmid">25636874</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>De Menezes</surname><given-names>J. P. B.</given-names></name><name><surname>Guedes</surname><given-names>C. E. S.</given-names></name><name><surname>Petersen</surname><given-names>A. L. d. O. A.</given-names></name><name><surname>Fraga</surname><given-names>D. B. M.</given-names></name><name><surname>Veras</surname><given-names>P. S. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Advances in Development of New Treatment for Leishmaniasis</article-title>. <source>Biomed. Res. Int.</source>
<volume>2015</volume>, <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1155/2015/815023</pub-id>
</mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Duarte</surname><given-names>M. C.</given-names></name><name><surname>Lagedos</surname><given-names>L. M. d. R. R.</given-names></name><name><surname>Lage</surname><given-names>D. P.</given-names></name><name><surname>Martins</surname><given-names>V. T.</given-names></name><name><surname>Carvalho</surname><given-names>A. M. R. S.</given-names></name><name><surname>Roatt</surname><given-names>B. M.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Treatment of Murine Visceral Leishmaniasis Using an 8-Hydroxyquinoline-Containing Polymeric Micelle System</article-title>. <source>Parasitol. Int.</source>
<volume>65</volume>, <fpage>728</fpage>&#x02013;<lpage>736</lpage>. <pub-id pub-id-type="doi">10.1016/j.parint.2016.07.005</pub-id>
<pub-id pub-id-type="pmid">27425599</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ebrahimi</surname><given-names>K.</given-names></name><name><surname>Shiravand</surname><given-names>S.</given-names></name><name><surname>Mahmoudvand</surname><given-names>H.</given-names></name></person-group> (<year>2017</year>). <article-title>Biosynthesis of Copper Nanoparticles Using Aqueous Extract of Capparis Spinosa Fruit and Investigation of its Antibacterial Activity</article-title>. <source>mpj</source>
<volume>21</volume>, <fpage>866</fpage>&#x02013;<lpage>871</lpage>. <pub-id pub-id-type="doi">10.12991/mpj.2017.31</pub-id>
</mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>El-Khadragy</surname><given-names>M.</given-names></name><name><surname>Alolayan</surname><given-names>E.</given-names></name><name><surname>Metwally</surname><given-names>D.</given-names></name><name><surname>El-Din</surname><given-names>M.</given-names></name><name><surname>Alobud</surname><given-names>S.</given-names></name><name><surname>Alsultan</surname><given-names>N.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Clinical Efficacy Associated with Enhanced Antioxidant Enzyme Activities of Silver Nanoparticles Biosynthesized Using Moringa Oleifera Leaf Extract, against Cutaneous Leishmaniasis in a Murine Model of Leishmania Major</article-title>. <source>Ijerph</source>
<volume>15</volume>, <fpage>1037</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph15051037</pub-id>
</mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fanti</surname><given-names>J. R.</given-names></name><name><surname>Tomiotto-Pellissier</surname><given-names>F.</given-names></name><name><surname>Miranda-Sapla</surname><given-names>M. M.</given-names></name><name><surname>Cataneo</surname><given-names>A. H. D.</given-names></name><name><surname>Andrade</surname><given-names>C. G. T. d. J.</given-names></name><name><surname>Panis</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Biogenic Silver Nanoparticles Inducing Leishmania Amazonensis Promastigote and Amastigote Death <italic>In Vitro</italic>
</article-title>. <source>Acta Tropica</source>
<volume>178</volume>, <fpage>46</fpage>&#x02013;<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.actatropica.2017.10.027</pub-id>
<pub-id pub-id-type="pmid">29111137</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghaffarifar</surname><given-names>F.</given-names></name><name><surname>Esavand Heydari</surname><given-names>F.</given-names></name><name><surname>Dalimi</surname><given-names>A.</given-names></name><name><surname>Hassan</surname><given-names>Z. M.</given-names></name><name><surname>Delavari</surname><given-names>M.</given-names></name><name><surname>Mikaeiloo</surname><given-names>H.</given-names></name></person-group> (<year>2015</year>). <article-title>Evaluation of Apoptotic and Antileishmanial Activities of Artemisinin on Promastigotes and BALB/C Mice Infected with Leishmania Major</article-title>. <source>Iran. J. Parasitol.</source>
</mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gharirvand Eskandari</surname><given-names>E.</given-names></name><name><surname>Setorki</surname><given-names>M.</given-names></name><name><surname>Doudi</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>Medicinal Plants with Antileishmanial Properties: A Review Study</article-title>. <source>Pbr</source>
<volume>6</volume>(<issue>11</issue>), <fpage>1</fpage>&#x02013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.18502/pbr.v6i1.3422</pub-id>
</mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ghobakhloo</surname><given-names>N.</given-names></name><name><surname>Motazedian</surname><given-names>M. H.</given-names></name><name><surname>Fardaei</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Expression Analysis of Multiple Genes May Involve in Antimony Resistance Among Leishmania Major Clinical Isolates from Fars Province, Central Iran</article-title>. <source>Iran. J. Parasitol.</source>
<volume>11</volume>(<issue>2</issue>), <fpage>168</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="pmid">28096850</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Glaser</surname><given-names>J.</given-names></name><name><surname>Schultheis</surname><given-names>M.</given-names></name><name><surname>Moll</surname><given-names>H.</given-names></name><name><surname>Hazra</surname><given-names>B.</given-names></name><name><surname>Holzgrabe</surname><given-names>U.</given-names></name></person-group> (<year>2015</year>). <article-title>Antileishmanial and Cytotoxic Compounds from Valeriana Wallichii and Identification of a Novel Nepetolactone Derivative</article-title>. <source>Molecules</source>
<volume>20</volume>, <fpage>5740</fpage>&#x02013;<lpage>5753</lpage>. <pub-id pub-id-type="doi">10.3390/molecules20045740</pub-id>
<pub-id pub-id-type="pmid">25834987</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hajaji</surname><given-names>S.</given-names></name><name><surname>Sifaoui</surname><given-names>I.</given-names></name><name><surname>L&#x000f3;pez-Arencibia</surname><given-names>A.</given-names></name><name><surname>Reyes-Batlle</surname><given-names>M.</given-names></name><name><surname>Jim&#x000e9;nez</surname><given-names>I. A.</given-names></name><name><surname>Bazzocchi</surname><given-names>I. L.</given-names></name><etal/></person-group> (<year>2018</year>). <article-title>Leishmanicidal Activity of &#x003b1;-bisabolol from Tunisian Chamomile Essential Oil</article-title>. <source>Parasitol. Res.</source>
<volume>117</volume>, <fpage>2855</fpage>&#x02013;<lpage>2867</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-018-5975-7</pub-id>
<pub-id pub-id-type="pmid">29955971</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hameed</surname><given-names>S.</given-names></name><name><surname>Ali Shah</surname><given-names>S.</given-names></name><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Numan</surname><given-names>M.</given-names></name><name><surname>Muhammad</surname><given-names>W.</given-names></name><name><surname>Junaid</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Cannabis Sativa-Mediated Synthesis of Gold Nanoparticles and Their Biomedical Properties</article-title>. <source>Bioinspired, Biomimetic and Nanobiomaterials</source>
<volume>9</volume>, <fpage>95</fpage>&#x02013;<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1680/jbibn.19.00023</pub-id>
</mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hameed</surname><given-names>S.</given-names></name><name><surname>Khalil</surname><given-names>A. T.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Numan</surname><given-names>M.</given-names></name><name><surname>Khamlich</surname><given-names>S.</given-names></name><name><surname>Shinwari</surname><given-names>Z. K.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Greener Synthesis of ZnO and Ag-ZnO Nanoparticles Using Silybum marianum for Diverse Biomedical Applications</article-title>. <source>Nanomedicine</source>
<volume>14</volume>, <fpage>655</fpage>&#x02013;<lpage>673</lpage>. <pub-id pub-id-type="doi">10.2217/nnm-2018-0279</pub-id>
<pub-id pub-id-type="pmid">30714480</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hotez</surname><given-names>P. J.</given-names></name><name><surname>Aksoy</surname><given-names>S.</given-names></name><name><surname>Brindley</surname><given-names>P. J.</given-names></name><name><surname>Kamhawi</surname><given-names>S.</given-names></name></person-group> (<year>2020</year>). <article-title>World Neglected Tropical Diseases Day</article-title>. <source>Plos Negl. Trop. Dis.</source>
<volume>14</volume>, <fpage>e0007999</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1371/JOURNAL.PNTD.0007999</pub-id>
<pub-id pub-id-type="pmid">31995572</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Iqbal</surname><given-names>J.</given-names></name><name><surname>Abbasi</surname><given-names>B. A.</given-names></name><name><surname>Mahmood</surname><given-names>T.</given-names></name><name><surname>Kanwal</surname><given-names>S.</given-names></name><name><surname>Ahmad</surname><given-names>R.</given-names></name><name><surname>Ashraf</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Plant-extract Mediated green Approach for the Synthesis of ZnONPs: Characterization and Evaluation of Cytotoxic, Antimicrobial and Antioxidant Potentials</article-title>. <source>J. Mol. Struct.</source>
<volume>1189</volume>, <fpage>315</fpage>&#x02013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.04.060</pub-id>
</mixed-citation></ref><ref id="B36"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Ismail</surname><given-names>H. H.</given-names></name><name><surname>Hasoon</surname><given-names>S. A.</given-names></name><name><surname>Saheb</surname><given-names>E. J.</given-names></name></person-group> (<year>2019</year>). <article-title>The Anti- Leishmaniasis Activity of green Synthesis Silver Oxide Nanoparticles</article-title>. <source>Ann. Trop. Med. Public Heal</source>
<volume>22</volume>, <fpage>28</fpage>&#x02013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.36295/ASRO.2019.22044</pub-id>
</mixed-citation></ref><ref id="B37"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jesus</surname><given-names>J. A.</given-names></name><name><surname>Fragoso</surname><given-names>T. N.</given-names></name><name><surname>Yamamoto</surname><given-names>E. S.</given-names></name><name><surname>Laurenti</surname><given-names>M. D.</given-names></name><name><surname>Silva</surname><given-names>M. S.</given-names></name><name><surname>Ferreira</surname><given-names>A. F.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>Therapeutic Effect of Ursolic Acid in Experimental Visceral Leishmaniasis</article-title>. <source>Int. J. Parasitol. Drugs Drug Resist</source>
<volume>7</volume> (<issue>11</issue>), <fpage>1</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="pmid">27984757</pub-id></mixed-citation></ref><ref id="B38"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Javed</surname><given-names>B.</given-names></name><name><surname>Raja</surname><given-names>N. I.</given-names></name><name><surname>Nadhman</surname><given-names>A.</given-names></name><name><surname>Mashwani</surname><given-names>Z.-u. -R.</given-names></name></person-group> (<year>2020</year>). <article-title>Understanding the Potential of Bio-Fabricated Non-oxidative Silver Nanoparticles to Eradicate Leishmania and Plant Bacterial Pathogens</article-title>. <source>Appl. Nanosci.</source>
<volume>10</volume>, <fpage>2057</fpage>&#x02013;<lpage>2067</lpage>. <pub-id pub-id-type="doi">10.1007/s13204-020-01355-5</pub-id>
</mixed-citation></ref><ref id="B39"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jhingran</surname><given-names>A.</given-names></name><name><surname>Chawla</surname><given-names>B.</given-names></name><name><surname>Saxena</surname><given-names>S.</given-names></name><name><surname>Barrett</surname><given-names>M. P.</given-names></name><name><surname>Madhubala</surname><given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Paromomycin: Uptake and Resistance in Leishmania Donovani</article-title>. <source>Mol. Biochem. Parasitol.</source>
<volume>164</volume>, <fpage>111</fpage>&#x02013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1016/j.molbiopara.2008.12.007</pub-id>
<pub-id pub-id-type="pmid">19146886</pub-id></mixed-citation></ref><ref id="B40"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>KarimiPourSaryazdi</surname><given-names>A.</given-names></name><name><surname>Ghaffarifar</surname><given-names>F.</given-names></name><name><surname>Dalimi</surname><given-names>A.</given-names></name><name><surname>Dayer</surname><given-names>M. S.</given-names></name></person-group> (<year>2020</year>). <article-title>
<italic>In-vitro</italic> and <italic>In-Vivo</italic> Comparative Effects of the spring and Autumn-Harvested Artemisia Aucheri Bioss Extracts on Leishmania Major</article-title>. <source>J. Ethnopharmacology</source>
<volume>257</volume>, <fpage>112910</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2020.112910</pub-id>
</mixed-citation></ref><ref id="B41"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kaye</surname><given-names>P.</given-names></name><name><surname>Scott</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Leishmaniasis: Complexity at the Host-Pathogen Interface</article-title>. <source>Nat. Rev. Microbiol.</source>
<volume>9</volume>, <fpage>604</fpage>&#x02013;<lpage>615</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro2608</pub-id>
<pub-id pub-id-type="pmid">21747391</pub-id></mixed-citation></ref><ref id="B42"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khalil</surname><given-names>A. T.</given-names></name><name><surname>Ovais</surname><given-names>M.</given-names></name><name><surname>Ullah</surname><given-names>I.</given-names></name><name><surname>Ali</surname><given-names>M.</given-names></name><name><surname>Jan</surname><given-names>S. A.</given-names></name><name><surname>Shinwari</surname><given-names>Z. K.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Bioinspired Synthesis of Pure Massicot Phase lead Oxide Nanoparticles and Assessment of Their Biocompatibility, Cytotoxicity and <italic>In-Vitro</italic> Biological Properties</article-title>. <source>Arabian J. Chem.</source>
<volume>13</volume>, <fpage>916</fpage>&#x02013;<lpage>931</lpage>. <pub-id pub-id-type="doi">10.1016/j.arabjc.2017.08.009</pub-id>
</mixed-citation></ref><ref id="B43"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Khatami</surname><given-names>M.</given-names></name><name><surname>Khatami</surname><given-names>S.</given-names></name><name><surname>Mosazade</surname><given-names>F.</given-names></name><name><surname>Raisi</surname><given-names>M.</given-names></name><name><surname>Haghighat</surname><given-names>M.</given-names></name><name><surname>Sabaghan</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Greener Synthesis of Rod Shaped Zinc Oxide NPs Using Lilium Ledebourii Tuber and Evaluation of Their Leishmanicidal Activity</article-title>. <source>Iranj. Biotechnol.</source>
<volume>18</volume>. <fpage>e2196</fpage>. <pub-id pub-id-type="doi">10.30498/ijb.2020.119481.2196</pub-id>
</mixed-citation></ref><ref id="B44"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kruszewski</surname><given-names>M.</given-names></name><name><surname>Brzoska</surname><given-names>K.</given-names></name><name><surname>Brunborg</surname><given-names>G.</given-names></name><name><surname>Asare</surname><given-names>N.</given-names></name><name><surname>Dobrzy&#x00144;ska</surname><given-names>M.</given-names></name><name><surname>Du&#x00161;insk&#x000e1;</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>&#x0201c;Toxicity of Silver Nanomaterials in Higher Eukaryotes&#x0201d;</article-title>. <source>Advances in Molecular Toxicology</source>, <volume>5</volume>, <fpage>179</fpage>&#x02013;<lpage>218</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-444-53864-2.00005-0</pub-id>
</mixed-citation></ref><ref id="B45"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kyriazis</surname><given-names>I. D.</given-names></name><name><surname>Koutsoni</surname><given-names>O. S.</given-names></name><name><surname>Aligiannis</surname><given-names>N.</given-names></name><name><surname>Karampetsou</surname><given-names>K.</given-names></name><name><surname>Skaltsounis</surname><given-names>A.-L.</given-names></name><name><surname>Dotsika</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>The Leishmanicidal Activity of Oleuropein Is Selectively Regulated through Inflammation- and Oxidative Stress-Related Genes</article-title>. <source>Parasites Vectors</source>
<volume>9</volume>. <fpage>441</fpage>. <pub-id pub-id-type="doi">10.1186/s13071-016-1701-4</pub-id>
<pub-id pub-id-type="pmid">27501956</pub-id></mixed-citation></ref><ref id="B146"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lage</surname><given-names>P. S.</given-names></name><name><surname>Ch&#x000e1;vez-Fumagalli</surname><given-names>M. A.</given-names></name><name><surname>Mesquita</surname><given-names>J. T.</given-names></name><name><surname>Mata</surname><given-names>L. M.</given-names></name><name><surname>Fernandes</surname><given-names>S. O. A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum</article-title>. <source>Parasitol. Res.</source>
<volume>114</volume> (<issue>12</issue>), <fpage>4625</fpage>-<lpage>4635</lpage>. <pub-id pub-id-type="doi">10.1007/s00436-015-4708-4</pub-id>
<pub-id pub-id-type="pmid">26346453</pub-id></mixed-citation></ref><ref id="B46"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mac&#x000ea;do</surname><given-names>C. G.</given-names></name><name><surname>Fonseca</surname><given-names>M. Y. N.</given-names></name><name><surname>Caldeira</surname><given-names>A. D.</given-names></name><name><surname>Castro</surname><given-names>S. P.</given-names></name><name><surname>Pacienza-Lima</surname><given-names>W.</given-names></name><name><surname>Borsodi</surname><given-names>M. P. G.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Leishmanicidal Activity of Piper Marginatum Jacq. From Santar&#x000e9;m-PA against Leishmania Amazonensis</article-title>. <source>Exp. Parasitol.</source>
<volume>210</volume>, <fpage>107847</fpage>. <pub-id pub-id-type="doi">10.1016/j.exppara.2020.107847</pub-id>
<pub-id pub-id-type="pmid">32004535</pub-id></mixed-citation></ref><ref id="B47"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maheshwari</surname><given-names>K. K.</given-names></name><name><surname>Bandyopadhyay</surname><given-names>D.</given-names></name></person-group> (<year>2021</year>). <article-title>Heterocycles in the Treatment of Neglected Tropical Diseases</article-title>. <source>Cmc</source>
<volume>28</volume>, <fpage>472</fpage>&#x02013;<lpage>495</lpage>. <pub-id pub-id-type="doi">10.2174/0929867327666200219141652</pub-id>
</mixed-citation></ref><ref id="B48"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maina</surname><given-names>E. N. M.</given-names></name><name><surname>Njau</surname><given-names>V. N.</given-names></name><name><surname>Gavamukulya</surname><given-names>Y.</given-names></name></person-group> (<year>2020</year>). <article-title>Phytochemical Analysis and Antileishmanial Activity of Clerodendrum Myricoides and Salvadora Persica Plant Extracts against Leishmania Major</article-title>. <source>Jocamr</source>
<volume>9</volume>(<issue>11</issue>), <fpage>29</fpage>&#x02013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.9734/jocamr/2020/v9i130134</pub-id>
</mixed-citation></ref><ref id="B49"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Maurya</surname><given-names>R.</given-names></name><name><surname>Chandrasekaran</surname><given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>A Novel Synergistic Composition for the Treatment of Visceral Leishmaniasis</article-title>. <comment>WO 2017046778</comment>. </mixed-citation></ref><ref id="B50"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mcgwire</surname><given-names>B. S.</given-names></name><name><surname>Satoskar</surname><given-names>A. R.</given-names></name></person-group> (<year>2014</year>). <article-title>Leishmaniasis: Clinical Syndromes and Treatment</article-title>. <source>QJM</source>
<volume>107</volume>, <fpage>7</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1093/qjmed/hct116</pub-id>
<pub-id pub-id-type="pmid">23744570</pub-id></mixed-citation></ref><ref id="B51"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Metwally</surname><given-names>D. M.</given-names></name><name><surname>Al-Olayan</surname><given-names>E. M.</given-names></name><name><surname>El-Khadragy</surname><given-names>M. F.</given-names></name><name><surname>Alkathiri</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>Anti-leishmanial Activity (<italic>In Vitro</italic> and <italic>In Vivo</italic>) of Allicin and Allicin Cream Using Leishmania Major (Sub-strain Zymowme LON4) and Balb/c Mice</article-title>. <source>PLoS One</source>
<volume>11</volume>, <fpage>e0161296</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0161296</pub-id>
<pub-id pub-id-type="pmid">27537199</pub-id></mixed-citation></ref><ref id="B52"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mirzaei</surname><given-names>F.</given-names></name><name><surname>Norouzi</surname><given-names>R.</given-names></name><name><surname>Siyadatpanah</surname><given-names>A.</given-names></name><name><surname>Mitsuwan</surname><given-names>W.</given-names></name><name><surname>Nilforoushzadeh</surname><given-names>M.</given-names></name><name><surname>Maleksabet</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Butanol Fraction of Kelussia Odoratissima Mozaff Inhibits the Growth of Leishmania Major Promastigote and Amastigote</article-title>. <source>jwpr</source>
<volume>10</volume>, <fpage>254</fpage>&#x02013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.36380/scil.2020.wvj33</pub-id>
</mixed-citation></ref><ref id="B53"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mitropoulos</surname><given-names>P.</given-names></name><name><surname>Konidas</surname><given-names>P.</given-names></name><name><surname>Durkin-Konidas</surname><given-names>M.</given-names></name></person-group> (<year>2010</year>). <article-title>New World Cutaneous Leishmaniasis: Updated Review of Current and Future Diagnosis and Treatment</article-title>. <source>J. Am. Acad. Dermatol.</source>
<volume>63</volume>, <fpage>309</fpage>&#x02013;<lpage>322</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2009.06.088</pub-id>
<pub-id pub-id-type="pmid">20303613</pub-id></mixed-citation></ref><ref id="B54"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moawad</surname><given-names>A.</given-names></name><name><surname>Hassan</surname><given-names>H.</given-names></name><name><surname>Amin</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>Biologically-Guided Isolation of Leishmanicidal Secondary Metabolites from Euphorbia Peplus L</article-title>. <source>Planta Med.</source>
<volume>82</volume>, <fpage>PC47</fpage>. <pub-id pub-id-type="doi">10.1055/s-0036-1578749</pub-id>
</mixed-citation></ref><ref id="B55"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Momeni</surname><given-names>A.</given-names></name><name><surname>Rasoolian</surname><given-names>M.</given-names></name><name><surname>Momeni</surname><given-names>A.</given-names></name><name><surname>Navaei</surname><given-names>A.</given-names></name><name><surname>Emami</surname><given-names>S.</given-names></name><name><surname>Shaker</surname><given-names>Z.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Development of Liposomes Loaded with Anti-leishmanial Drugs for the Treatment of Cutaneous Leishmaniasis</article-title>. <source>J. Liposome Res.</source>
<volume>23</volume>, <fpage>134</fpage>&#x02013;<lpage>144</lpage>. <pub-id pub-id-type="doi">10.3109/08982104.2012.762519</pub-id>
<pub-id pub-id-type="pmid">23350940</pub-id></mixed-citation></ref><ref id="B56"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moreira</surname><given-names>R. R. D.</given-names></name><name><surname>SantosDos</surname><given-names>A. G. d.</given-names></name><name><surname>Carvalho</surname><given-names>F. A.</given-names></name><name><surname>Perego</surname><given-names>C. H.</given-names></name><name><surname>Crevelin</surname><given-names>E. J.</given-names></name><name><surname>Crotti</surname><given-names>A. E. M.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Antileishmanial Activity of Melampodium Divaricatum and Casearia Sylvestris Essential Oils on Leishmania Amazonensis</article-title>. <source>Rev. Inst. Med. Trop. S. Paulo</source>
<volume>61</volume>. <fpage>e33</fpage>. <pub-id pub-id-type="doi">10.1590/s1678-9946201961033</pub-id>
<pub-id pub-id-type="pmid">31269109</pub-id></mixed-citation></ref><ref id="B57"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moreno</surname><given-names>E.</given-names></name><name><surname>Schwartz</surname><given-names>J.</given-names></name><name><surname>Larrea</surname><given-names>E.</given-names></name><name><surname>Conde</surname><given-names>I.</given-names></name><name><surname>Font</surname><given-names>M.</given-names></name><name><surname>Sanmart&#x000ed;n</surname><given-names>C.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Assessment of &#x003b2;-lapachone Loaded in Lecithin-Chitosan Nanoparticles for the Topical Treatment of Cutaneous Leishmaniasis in L. Major Infected BALB/c Mice</article-title>. <source>Nanomedicine: Nanotechnology, Biol. Med.</source>
<volume>11</volume>, <fpage>2003</fpage>&#x02013;<lpage>2012</lpage>. <pub-id pub-id-type="doi">10.1016/j.nano.2015.07.011</pub-id>
</mixed-citation></ref><ref id="B58"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>D.</given-names></name><name><surname>Singh</surname><given-names>C. B.</given-names></name><name><surname>Dey</surname><given-names>S.</given-names></name><name><surname>Mandal</surname><given-names>S.</given-names></name><name><surname>Ghosh</surname><given-names>J.</given-names></name><name><surname>Mallick</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Induction of Apoptosis by Zerumbone Isolated from Zingiber Zerumbet (L.) Smith in Protozoan Parasite Leishmania Donovani Due to Oxidative Stress</article-title>. <source>Braz. J. Infect. Dis.</source>
<volume>20</volume>, <fpage>48</fpage>&#x02013;<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1016/j.bjid.2015.10.002</pub-id>
<pub-id pub-id-type="pmid">26643969</pub-id></mixed-citation></ref><ref id="B59"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Naz</surname><given-names>S.</given-names></name><name><surname>Islam</surname><given-names>M.</given-names></name><name><surname>Tabassum</surname><given-names>S.</given-names></name><name><surname>Fernandes</surname><given-names>N. F.</given-names></name><name><surname>Carcache de Blanco</surname><given-names>E. J.</given-names></name><name><surname>Zia</surname><given-names>M.</given-names></name></person-group> (<year>2019</year>). <article-title>Green Synthesis of Hematite (&#x003b1;-Fe2O3) Nanoparticles Using Rhus Punjabensis Extract and Their Biomedical prospect in Pathogenic Diseases and Cancer</article-title>. <source>J. Mol. Struct.</source>
<volume>1185</volume>, <fpage>1</fpage>&#x02013;<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/j.molstruc.2019.02.088</pub-id>
</mixed-citation></ref><ref id="B60"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Noormehr</surname><given-names>H.</given-names></name><name><surname>Zavaran Hosseini</surname><given-names>A.</given-names></name><name><surname>Soudi</surname><given-names>S.</given-names></name><name><surname>Beyzay</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Enhancement of Th1 Immune Response against Leishmania Cysteine Peptidase A, B by PLGA Nanoparticle</article-title>. <source>Int. Immunopharmacology</source>
<volume>59</volume>, <fpage>97</fpage>&#x02013;<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.intimp.2018.03.012</pub-id>
</mixed-citation></ref><ref id="B61"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Olekhnovitch</surname><given-names>R.</given-names></name><name><surname>Ryffel</surname><given-names>B.</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>A. J.</given-names></name><name><surname>Bousso</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Collective Nitric Oxide Production Provides Tissue-wide Immunity during Leishmania Infection</article-title>. <source>J. Clin. Invest.</source>
<volume>124</volume>, <fpage>1711</fpage>&#x02013;<lpage>1722</lpage>. <pub-id pub-id-type="doi">10.1172/JCI72058</pub-id>
<pub-id pub-id-type="pmid">24614106</pub-id></mixed-citation></ref><ref id="B62"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oryan</surname><given-names>A.</given-names></name><name><surname>Akbari</surname><given-names>M.</given-names></name></person-group> (<year>2016</year>). <article-title>Worldwide Risk Factors in Leishmaniasis</article-title>. <source>Asian Pac. J. Trop. Med.</source>
<volume>9</volume>, <fpage>925</fpage>&#x02013;<lpage>932</lpage>. <pub-id pub-id-type="doi">10.1016/j.apjtm.2016.06.021</pub-id>
<pub-id pub-id-type="pmid">27794384</pub-id></mixed-citation></ref><ref id="B63"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oryan</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Plant-derived Compounds in Treatment of Leishmaniasis</article-title>. <source>Iranj. Vet. Res.</source>
<volume>16</volume>(<issue>1</issue>), <fpage>1</fpage>&#x02013;<lpage>19</lpage>. <pub-id pub-id-type="doi">10.22099/ijvr.2015.2917</pub-id>
</mixed-citation></ref><ref id="B64"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Park</surname><given-names>E.-J.</given-names></name><name><surname>Yi</surname><given-names>J.</given-names></name><name><surname>Kim</surname><given-names>Y.</given-names></name><name><surname>Choi</surname><given-names>K.</given-names></name><name><surname>Park</surname><given-names>K.</given-names></name></person-group> (<year>2010</year>). <article-title>Silver Nanoparticles Induce Cytotoxicity by a Trojan-Horse Type Mechanism</article-title>. <source>Toxicol. Vitro</source>
<volume>24</volume>, <fpage>872</fpage>&#x02013;<lpage>878</lpage>. <pub-id pub-id-type="doi">10.1016/j.tiv.2009.12.001</pub-id>
</mixed-citation></ref><ref id="B65"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Pereira</surname><given-names>K. L. G.</given-names></name><name><surname>Vasconcelos</surname><given-names>N. B. R.</given-names></name><name><surname>Braz</surname><given-names>J. V. C.</given-names></name><name><surname>In&#x000e1;cio</surname><given-names>J. D. F.</given-names></name><name><surname>Estevam</surname><given-names>C. S.</given-names></name><name><surname>Correa</surname><given-names>C. B.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Ethanolic Extract of Croton Blanchetianus ball Induces Mitochondrial Defects in Leishmania Amazonensis Promastigotes</article-title>. <source>Acad. Bras. Ci&#x000ea;nc.</source>
<volume>92</volume>. <fpage>e20180968</fpage>. <pub-id pub-id-type="doi">10.1590/0001-3765202020180968</pub-id>
</mixed-citation></ref><ref id="B66"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Prasanna</surname><given-names>P.</given-names></name><name><surname>Kumar</surname><given-names>P.</given-names></name><name><surname>Mandal</surname><given-names>S.</given-names></name><name><surname>Patyal</surname><given-names>T.</given-names></name><name><surname>Patyal</surname><given-names>T.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Das</surname><given-names>P.</given-names></name><etal/></person-group>
<year>(2020)</year>. <article-title>Synthesis of 7, 8&#x02013;dihydroxyflavone Functionalized Gold Nanoparticles and its Mechanism of Action against Leishmania Donovani</article-title>. <source>Res. Square</source>
<fpage>1</fpage>&#x02013;<lpage>29</lpage>. <pub-id pub-id-type="doi">10.21203/rs.3.rs-37873/v3</pub-id>
</mixed-citation></ref><ref id="B67"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Robledo</surname><given-names>S. M.</given-names></name><name><surname>Cardona</surname><given-names>W.</given-names></name><name><surname>Ligardo</surname><given-names>K.</given-names></name><name><surname>Henao</surname><given-names>J.</given-names></name><name><surname>Arbel&#x000e1;ez</surname><given-names>N.</given-names></name><name><surname>Montoya</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Antileishmanial Effect of 5,3&#x02032;-Hydroxy-7,4&#x02032;-Dimethoxyflavanone ofPicramnia gracilisTul. (Picramniaceae) Fruit:In VitroandIn VivoStudies</article-title>. <source>Adv. Pharmacol. Sci.</source>
<volume>2015</volume>, <fpage>1</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1155/2015/978379</pub-id>
</mixed-citation></ref><ref id="B68"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rosas-Hern&#x000e1;ndez</surname><given-names>H.</given-names></name><name><surname>Jim&#x000e9;nez-Badillo</surname><given-names>S.</given-names></name><name><surname>Mart&#x000ed;nez-Cuevas</surname><given-names>P. P.</given-names></name><name><surname>Gracia-Espino</surname><given-names>E.</given-names></name><name><surname>Terrones</surname><given-names>H.</given-names></name><name><surname>Terrones</surname><given-names>M.</given-names></name><etal/></person-group> (<year>2009</year>). <article-title>Effects of 45-nm Silver Nanoparticles on Coronary Endothelial Cells and Isolated Rat Aortic Rings</article-title>. <source>Toxicol. Lett.</source>
<volume>191</volume>, <fpage>305</fpage>&#x02013;<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2009.09.014</pub-id>
<pub-id pub-id-type="pmid">19800954</pub-id></mixed-citation></ref><ref id="B69"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Rossi</surname><given-names>D.</given-names></name><name><surname>Ahmed</surname><given-names>K.</given-names></name><name><surname>Gaggeri</surname><given-names>R.</given-names></name><name><surname>Della Volpe</surname><given-names>S.</given-names></name><name><surname>Maggi</surname><given-names>L.</given-names></name><name><surname>Mazzeo</surname><given-names>G.</given-names></name><etal/></person-group> (<year>2017</year>). <article-title>(R)-(&#x02212;)-Aloesaponol III 8-Methyl Ether from Eremurus Persicus: A Novel Compound against Leishmaniosis</article-title>. <source>Molecules</source>
<volume>22</volume>, <fpage>519</fpage>. <pub-id pub-id-type="doi">10.3390/molecules22040519</pub-id>
</mixed-citation></ref><ref id="B70"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Salama</surname><given-names>I. C.</given-names></name><name><surname>Arrais-Lima</surname><given-names>C.</given-names></name><name><surname>Arrais-Silva</surname><given-names>W. W.</given-names></name></person-group> (<year>2017</year>). <article-title>Evaluation of Boldine Activity against Intracellular Amastigotes of Leishmania Amazonensis</article-title>. <source>Korean J. Parasitol.</source>
<volume>55</volume>, <fpage>337</fpage>&#x02013;<lpage>340</lpage>. <pub-id pub-id-type="doi">10.3347/kjp.2017.55.3.337</pub-id>
<pub-id pub-id-type="pmid">28719960</pub-id></mixed-citation></ref><ref id="B71"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saleh</surname><given-names>A. H.</given-names></name></person-group> (<year>2019</year>). <article-title>Potential Role of Titanium Dioxide (TiO2) Nanoparticles against the Toxicity of Leishmania Tropica in Adult Albino Male Rats</article-title>. <source>JGPT</source>
<volume>11</volume> (<issue>3</issue>), <fpage>453</fpage>&#x02013;<lpage>457</lpage>. </mixed-citation></ref><ref id="B72"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Saljoughian</surname><given-names>N.</given-names></name><name><surname>Zahedifard</surname><given-names>F.</given-names></name><name><surname>Doroud</surname><given-names>D.</given-names></name><name><surname>Doustdari</surname><given-names>F.</given-names></name><name><surname>Vasei</surname><given-names>M.</given-names></name><name><surname>Papadopoulou</surname><given-names>B.</given-names></name><etal/></person-group> (<year>2013</year>). <article-title>Cationic Solid-Lipid Nanoparticles Are as Efficient as Electroporation in DNA Vaccination against Visceral Leishmaniasis in Mice</article-title>. <source>Parasite Immunol.</source>
<volume>35</volume>, <fpage>397</fpage>&#x02013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1111/pim.12042</pub-id>
<pub-id pub-id-type="pmid">23710803</pub-id></mixed-citation></ref><ref id="B73"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Santana</surname><given-names>R. C.</given-names></name><name><surname>Rosados</surname><given-names>A. d. S. S.</given-names></name><name><surname>Mateus</surname><given-names>M. H. d. S.</given-names></name><name><surname>Soares</surname><given-names>D. C.</given-names></name><name><surname>Atella</surname><given-names>G.</given-names></name><name><surname>Guimar&#x000e3;es</surname><given-names>A. C.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>
<italic>In Vitro</italic> leishmanicidal Activity of Monoterpenes Present in Two Species of Protium (Burseraceae) on Leishmania Amazonensis</article-title>. <source>J. Ethnopharmacology</source>
<volume>259</volume>, <fpage>112981</fpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2020.112981</pub-id>
</mixed-citation></ref><ref id="B74"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shah</surname><given-names>S.</given-names></name><name><surname>Ullah</surname><given-names>F.</given-names></name><name><surname>Ayaz</surname><given-names>M.</given-names></name><name><surname>Sadiq</surname><given-names>A.</given-names></name><name><surname>Hussain</surname><given-names>S.</given-names></name><name><surname>Ali Shah</surname><given-names>A.-U. -H.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>Benzoic Acid Derivatives of Ifloga Spicata (Forssk.) Sch.Bip. As Potential Anti-leishmanial against Leishmania Tropica</article-title>. <source>Processes</source>, <volume>7</volume>, <fpage>208</fpage>. <pub-id pub-id-type="doi">10.3390/pr7040208</pub-id>
</mixed-citation></ref><ref id="B75"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shaheen</surname><given-names>N.</given-names></name><name><surname>Qureshi</surname><given-names>N. A.</given-names></name><name><surname>Ashraf</surname><given-names>A.</given-names></name><name><surname>Hamid</surname><given-names>A.</given-names></name><name><surname>Iqbal</surname><given-names>A.</given-names></name><name><surname>Fatima</surname><given-names>H.</given-names></name></person-group> (<year>2020</year>). <article-title>
<italic>In Vitro</italic> anti-leishmanial Activity of Prunus Armeniaca Fractions on Leishmania Tropica and Molecular Docking Studies</article-title>. <source>J. Photochem. Photobiol. B: Biol.</source>
<volume>213</volume>, <fpage>112077</fpage>. <pub-id pub-id-type="doi">10.1016/j.jphotobiol.2020.112077</pub-id>
</mixed-citation></ref><ref id="B76"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sharma</surname><given-names>R.</given-names></name><name><surname>Gupta</surname><given-names>V.</given-names></name><name><surname>Chawla</surname><given-names>V.</given-names></name><name><surname>Chawla</surname><given-names>P.</given-names></name></person-group> (<year>2019</year>). <article-title>Exploring the Possible Role of Nature in Curing Leishmaniasis</article-title>. <source>Jamps</source>, <volume>20</volume>(<issue>3</issue>), <fpage>1</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.9734/jamps/2019/v20i330114</pub-id>
</mixed-citation></ref><ref id="B77"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shoaib Sarwar</surname><given-names>H.</given-names></name><name><surname>Varikuti</surname><given-names>S.</given-names></name><name><surname>Farhan Sohail</surname><given-names>M.</given-names></name><name><surname>Sarwar</surname><given-names>M.</given-names></name><name><surname>Akhtar</surname><given-names>S.</given-names></name><name><surname>Satoskar</surname><given-names>A. R.</given-names></name><etal/></person-group> (<year>2020</year>). <article-title>Oral Delivery and Enhanced Efficacy of Antimonal Drug through Macrophage-Guided Multifunctional Nanocargoes against Visceral Leishmaniasis</article-title>. <source>Eur. J. Pharmaceutics Biopharmaceutics</source>
<volume>152</volume>, <fpage>307</fpage>&#x02013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpb.2020.05.029</pub-id>
</mixed-citation></ref><ref id="B78"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Silveira</surname><given-names>E. S.</given-names></name><name><surname>Castro Rodrigues</surname><given-names>N. L. D.</given-names></name><name><surname>Machado</surname><given-names>N. J.</given-names></name><name><surname>Marciano Fonseca</surname><given-names>F. R.</given-names></name><name><surname>Teixeira</surname><given-names>M. J.</given-names></name><name><surname>Almeida Moreira Leal</surname><given-names>L. K.</given-names></name></person-group> (<year>2021</year>). <article-title>Medicinal Plants Containing Coumarin or Essential Oils from the Brazilian Biome May Be New Option for Treating Leishmaniasis?</article-title>. <source>Phrev</source>
<volume>14</volume>, <fpage>53</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.5530/phrev.2020.14.9</pub-id>
</mixed-citation></ref><ref id="B79"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Sundar</surname><given-names>S.</given-names></name><name><surname>Sinha</surname><given-names>P. K.</given-names></name><name><surname>Rai</surname><given-names>M.</given-names></name><name><surname>Verma</surname><given-names>D. K.</given-names></name><name><surname>Nawin</surname><given-names>K.</given-names></name><name><surname>Alam</surname><given-names>S.</given-names></name><etal/></person-group> (<year>2011</year>). <article-title>Comparison of Short-Course Multidrug Treatment with Standard Therapy for Visceral Leishmaniasis in India: An Open-Label, Non-inferiority, Randomised Controlled Trial</article-title>. <source>Lancet</source>
<volume>377</volume>(<issue>9764</issue>), <fpage>477</fpage>&#x02013;<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(10)62050-8</pub-id>
<pub-id pub-id-type="pmid">21255828</pub-id></mixed-citation></ref><ref id="B80"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Surur</surname><given-names>A. S.</given-names></name><name><surname>Fekadu</surname><given-names>A.</given-names></name><name><surname>Makonnen</surname><given-names>E.</given-names></name><name><surname>Hailu</surname><given-names>A.</given-names></name></person-group> (<year>2020</year>). <article-title>Challenges and Opportunities for Drug Discovery in Developing Countries: The Example of Cutaneous Leishmaniasis</article-title>. <source>ACS Med. Chem. Lett.</source>
<volume>11</volume>, <fpage>2058</fpage>&#x02013;<lpage>2062</lpage>. <pub-id pub-id-type="doi">10.1021/acsmedchemlett.0c00446</pub-id>
<pub-id pub-id-type="pmid">33214808</pub-id></mixed-citation></ref><ref id="B81"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vendruscolo</surname><given-names>M. H.</given-names></name><name><surname>das Neves</surname><given-names>G. M.</given-names></name><name><surname>Kagami</surname><given-names>L. P.</given-names></name><name><surname>Rodrigues Junior</surname><given-names>L. C.</given-names></name><name><surname>Nunes Diehl</surname><given-names>M. L.</given-names></name><name><surname>Gnoatto</surname><given-names>S. C. B.</given-names></name><etal/></person-group> (<year>2019</year>). <article-title>
<italic>In Vitro</italic> and In Silico Activity of Iridoids against Leishmania Amazonensis</article-title>. <source>Cddt</source>
<volume>16</volume>, <fpage>173</fpage>&#x02013;<lpage>183</lpage>. <pub-id pub-id-type="doi">10.2174/1570163814666171002102058</pub-id>
</mixed-citation></ref><ref id="B82"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Verma</surname><given-names>N. K.</given-names></name><name><surname>Dey</surname><given-names>C. S.</given-names></name></person-group> (<year>2004</year>). <article-title>Possible Mechanism of Miltefosine-Mediated Death of Leishmania Donovani</article-title>. <source>Aac</source>
<volume>48</volume>, <fpage>3010</fpage>&#x02013;<lpage>3015</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.48.8.3010-3015.2004</pub-id>
</mixed-citation></ref><ref id="B83"><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Zahir</surname><given-names>A. A.</given-names></name><name><surname>Chauhan</surname><given-names>I. S.</given-names></name><name><surname>Bagavan</surname><given-names>A.</given-names></name><name><surname>Kamaraj</surname><given-names>C.</given-names></name><name><surname>Elango</surname><given-names>G.</given-names></name><name><surname>Shankar</surname><given-names>J.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Green Synthesis of Silver and Titanium Dioxide Nanoparticles Using Euphorbia Prostrata Extract Shows Shift from Apoptosis to G0/G1Arrest Followed by Necrotic Cell Death in Leishmania Donovani</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>59</volume>, <fpage>4782</fpage>&#x02013;<lpage>4799</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00098-15</pub-id>
<pub-id pub-id-type="pmid">26033724</pub-id></mixed-citation></ref></ref-list></back></article>